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Telomeres help maintain the overall genomic stability of an organism, and telomeric homeostasis 
is critical to navigating between aging and cancer. Telomeric dysfunction is implicated as a 
contributing factor in numerous aging-related diseases, such as diabetes, impaired hematopoeisis, 
and atherosclerosis.  Telomeric homeostasis is maintained by a shelterin complex of six proteins 
and an array of telomere-associated proteins that interact with the central shelterin complex, such 
as the Werner syndrome helicase/exonuclease protein (WRN) or p53. Telomeres also have non-
canonical DNA structures that are critical towards their function, especially G-quadruplex DNA 
(G4 DNA) and Holliday Junctions. The former are pseudoknots that form on the G-rich 3’ 
single-stranded tail of the telomere and may block telomere replication and lengthening, when 
the 3’ telomeric tail is exposed in the “open” conformation. We found that the shelterin protein 
protection of telomeres 1 (POT1) competes with and destabilizes G4 DNA on a physiologically 
realistic telomeric tail substrate, leading to an equilibrium population of diminished G4 DNA 
coexisting with POT1. While POT1 is a passive binder of DNA, the destabilizing effect of bound 
POT1 on pre-existing G4 DNA leads to an emergent, de facto cooperativity in G4 DNA 
unfolding by POT1. 
Holliday Junctions (HJ) form when the telomere is in a “closed” conformation, in which 
the 3’ telomeric tail invades the duplex telomeric DNA, creating a displacement loop (D-loop) 
and sequestering the end of the chromosome from unwanted DNA damage responses. The D-
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loop is a homologous recombination intermediate, and we demonstrate that telomere repeat 
binding factor 2 (TRF2) is necessary to protect HJ DNA from unwanted WRN helicase activity, 
which has been thought to branch migrate the D-loop into a target for Holliday Junction cleaving 
enzymes, causing sudden telomere shortening. TRF2 also protects HJ DNA from Holliday 
Junction cleaving enzymes, and the cleavage protection is due largely to the HJ-binding B-
domain on TRF2. In contrast, we found that TRF2-mediated protection against WRN depends on 
both the B domain and the telomeric-repeat binding Myb domain. We have therefore discovered 
an overlapping but distinct role for TRF2 in maintaining telomeric stability. 
Our work has elucidated novel structural and functional data on the modulation of non-
canonical DNA structures by shelterin and telomere-associated proteins. These data help us 
elucidate the mechanisms underlying cellular and animal models for telomere instability and 
aging.  
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1.1 TELOMERES AND AGING 
 
1.1.1 Telomere dysfunction and aging 
The telomere is composed of repetitive DNA at the ends of linear chromosomes and protects the 
genome against two endogenous threats to genomic stability(1). First, along with telomerase, the 
telomere protects the genome against the inability of DNA replication machinery to completely 
replicate the ends of chromosomes. Secondly, the telomere and the associated shelterin complex 
of proteins sequester the ends of the chromosomes from the cell’s DNA double-strand break 
repair machinery. The latter function is tightly choreographed by the six shelterin proteins and 
shelterin interacting accessory proteins such as the Werner Syndrome  helicase/exonuclease 
(WRN) enzyme and p53(1).  
Telomere length and stability are related concepts that underlie the link between 
telomeres on one hand and disease and aging on the other. Mean telomere lengths do decrease 
with cell division(2), leading to telomeric dysfunction (3). Telomeric dysfunction in turn can 
lead to senescence and tissue dysfunction, such as in bone marrow(4) and vascular endothelial 
cells in atherosclerotic blood arteries(5). According to the classical model of telomeres and 
aging, when the cell has divided a certain number of times—i.e., has reached its Hayflick limit—
or has a critically shortened telomere, it must either senescence, apoptose, lengthen the 
telomeres, or mutate the p53/Rb checkpoints that guard against critically shortened 
telomeres(reviewed in(6)). The latter pathway is characteristic of the development of a cancerous 
cell. However, even a cell with adequate telomere lengths may experience genomic instability or 
premature senescence if the shelterin complex or another important shelterin interacting 
accessory   protein like WRN is not functional(1;7). 
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1.1.2 Werner Syndrome and telomeric dysfunction as model of aging 
Shortened telomeres are correlated with numerous age-related diseases, such as 
atherosclerosis(5), impaired wound healing(8), type II diabetes(9), reduced hematopoeisis(4;10), 
and cancer(3). Patients with the progeroid disease Werner Syndrome (WS) manifest many age-
related diseases prematurely as a result of lacking functional WRN enzyme(11), and die in their 
mid-fifties on average(12). While no single model system or biomarker exists for aging, Werner 
Syndrome provides the opportunity to study numerous tissue-specific age-related pathologies 
that have made it a common model for aging, with the additional advantage that WS patients 
have no characteristic anatomic phenotypes (e.g., craniofacial features), such as in Hutchinson-
Gilford Progeria (HGP)(11).  WS patients thus have a more “wild-type” appearance and their 
condition is less obvious than other progeria like ataxia-telangiectasia or HGP(13), which 
suggests that WS may provide a better model for aging in the general population than other 
progeria. 
While WS cells experience normal rates of shortening(14) and the mean telomere lengths 
are not shorter than in normal cells(15), WS cells experience an accelerated rate of stochastic 
telomere loss from individual chromatids(16).  Moreover, the forced expression of telomerase in 
human WS fibroblasts suppresses multiple WS phenotypes, including premature senescence(17), 
sister chromatid telomere loss(18), and chromosomal instability(18). The Wrn -/- mouse model 
displayed no unique phenotype unless the telomerase Terc gene was also knocked out and the 
telomeres were allowed to progressively shorten over several generations(19). Therefore, the 
value of Werner Syndrome (however imperfect) as a model of aging is linked to telomere 
dysfunction, but the underlying biochemical and biophysical mechanisms for the telomere-
 4 
related genomic instability and their subsequent effects on premature aging have yetto be 
elucidated.  
 
1.2 THE WRN HELICASE/EXONUCLEASE 
1.2.1 WRN structure and function 
As a RecQ helicase with an N-terminal exonuclease domain(20) (Fig. 1.1), WRN has a complex 
structure with a rich array of protein-protein and protein-DNA interactions that modulate its 
activity. As with all RecQ helicases, WRN has two RecA-like domains plus the RecQ-
characteristic RecQ Conserved (RQC) and HRDC domains(11). The RQC domain contains a Zn-
finger motif that is critical for protein stability in the Eschericia  coli (E. coli) homolog of 
WRN(21) and also contains the winged helix WH domain, which has both DNA-binding and 
unwinding roles (22). In the latter case, mutations of the WH domain could eliminate WRN 
binding to Holliday Junction (HJ) DNA(22).  A recent cocrystal of duplex DNA and a WRN 
fragment revealed that one of the hairpin-motif "wings" separates DNA base pairs(23). The WH 
domain modulates WRN binding and processivity on DNA substrates(24). 
The Helicase and RNAseD C-terminal (HRDC) domain, in contrast to the WH domain, 
does not bind single-stranded or forked DNA substrates(25). Rather, the HRDC domains seems 
to be purely a target of protein-protein interactions, such as p53, which interacts with WRN via 
the HRDC, and inhibits WRN activity on model replication forks and forked double stranded 
DNA (dsDNA) in vitro(26). WRN protein has a rich array of sites that interact with DNA and 
proteins, including several shelterin and shelterin interacting accessory   proteins(26-29). WRN 
is a RecQ helicase which unwinds DNA in a 3’ to 5’ direction(30), and uniquely has an 
exonuclease domain that also displays a 3’ to 5’ directionality(31). These domains process DNA 
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in coordination with each other (Fig. 1.2), allowing WRN to displace DNA substrates that the 
helicase domain could unwind alone(32). As a RecQ helicase, WRN has substrate affinities for 
DNA structures relevant to genomic maintenance in general, with some being of particular 
relevance to the telomere, including G-quadruplex (G4) DNA, displacement loops  (D-loops) and 
Holliday Junction (HJ) DNA (30;34). 
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Fig. 1.1  Schematic of the major domains in WRN helicase/exonuclease. The helicase, RecQ 
Conserved (RQC) and HRDC domains are characteristic of RecQ helicases. The N-terminal 
exonuclease domain is unique to WRN among the human RecQ helicases(11). 
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Fig. 1.2  Example of coordinate WRN helicase and exonuclease activity on a DNA fork. The 
helicase and exonuclease domains attack the substrate in an antiparallel manner in order to 
displace the exonuclease-shortened blue upper oligonucleotide(see (33)). 
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1.3 ALTERNATIVE DNA STRUCTURES AT THE TELOMERE 
 
Non-canonical DNA structures (i.e., non B-helical dsDNA) are functionally significant within 
the telomere, modulating and being modulated by shelterin and shelterin interacting accessory 
proteins. The human telomere sequence is composed of TTAGGG repeats, first as duplex DNA 
and as a 3’ strand continuing as a single-stranded DNA (ssDNA) extending tail beyond the 
duplex region (Fig. 1.3). The disposition of the ssDNA tail determines the two primary 
conformations of the telomere. 
 The first telomere conformation (“closed”) is where the DNA end is sequestered by the 
t-loop/D-loop structure. Bound TRF2 dimerizes and the 3’ tail is bent around, creating the lasso-
like t-loop and invades the upstream duplex telomeric DNA, displacing the G-rich strand and 
creating a displacement loop (D-loop) (35). The machinery involved in creating the D-loop 
structure includes the TRF1/2 shelterin proteins and the homologous recombination proteins 
RAD51, RAD52, RPA54 and XRCC3(36). The D-loop is a recombination intermediate, and 
research has shown that telomeres can be cleaved by Holliday Junction resolvases(37), indicating 
that the D-loop may branch migrate to a full Holliday Junction intermediate as will be discussed 
in further detail below. 
In addition to duplex DNA, the telomere has a 3’  tail of single-stranded DNA (ssDNA), 
composed of 50-100 nucleotides in the case of human cells(38). In the “extended” telomere 
conformation, the tail is exposed, as it would need to be for replication or extension by 
telomerase(1). 
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1.3.1 Mechanisms of WRN function at the telomere 
WRN protein has been shown to colocalize to telomeres during S-phase when the genome is 
replicated(39), and WS cells have prolonged S-phases, suggesting that WRN functions to clear 
barriers to replication(40). 
WRN unwinds G4 DNA (30), and all RecQ helicases share a G4 DNA binding motif in 
the RecQ Conserved (RQC) domain (41).  In addition to prolonged S-phases in WS(40),  WRN 
protein is required for the replication of the G-rich lagging strand of the telomere (18;42), 
indicating that G4 DNA may be a barrier to replication without WRN protein. Another study 
found lagging-strand sister telomere loss upon expression of a dominant negative WRN protein 
(18). WRN has been shown to interact with polymerase δ in vitro, allowing it to synthesize DNA 
through a quadruplex-forming region on the template strand(43).  
In addition to G4 DNA, WRN binds to and displaces HJ DNA in vitro(30) and WS cells 
have defects in homologous recombination (HR)-mediated repair of replication forks, which can 
be suppressed by the simultaneous knockout of RAD51 in WS cells (44). RAD51 binds single 
stranded DNA (ssDNA) as an initial step in HR; RecQ helicases can suppress RAD51-mediated 
HR by displacing DNA-bound RAD51(45). Both helicase and exonuclease functions must be 
present in exogenously expressed WRN in order to process HR intermediates in WS indicating 
that the two domains work coordinately to resolve HJ DNA(46). While both the helicase(30) and 
exonuclease domains(31) of WRN are known to process HJ DNA, no experimental data have yet 
shown coordinated activity between the two on an HJ substrate.  
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Fig. 1.3 Comparison of the open and closed conformations of the telomere. The three DNA-
binding proteins are depicted binding where they can localize in either conformation. Green 
ellipse, TRF2; red ellipse, TRF1; blue circle, POT1 (1). 
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1.3.2 Telomeres are protected by the shelterin complex 
The telomere is protected by six proteins comprising the shelterin complex(1). Three proteins 
(POT1, TRF1 and TRF2) directly bind telomeric DNA, and the other three (RAP1, TPP1 and 
TIN2) coordinate between each other and the DNA-binding shelterin proteins.  
The protection of telomeres 1 (POT1) protein binds the G-rich telomeric ssDNA, 
recognizing the sequence TTAGGGTTAG, thus targeting either the extended 3’ tail or the 
displaced G-rich strand in the D-loop. The N-terminal portion of POT1 has been crystallized, 
revealing a monomer that binds ssDNA via two oligonucleotide/oligosaccharide binding (OB) 
folds and a “pocket” that conceals the 3’ end of the TTAGGTAG binding sequence(47). This 
latter feature explains how POT1 has a position-dependent effect on telomerase activity, 
inhibiting telomerase when the POT1 is at the 3’ end (and thus sequestering the telomeric DNA) 
but promoting telomerase activity when further upstream(48).  POT1 also recruits the shelterin 
protein TPP1 to the telomere. TPP1 adds another layer of control for telomerase activity, as it 
recruits telomerase to the telomere and increases its processivity(49).  In the extended telomere 
conformation where the ssDNA tail is exposed, the shelterin complex, via POT1 binding the 
telomeric ssDNA, protects the 3’ tail from unwanted ATM and Rad3-related protein (ATR) 
activation against the ssDNA as a response to stalled replication forks (36).  
Telomere Repeat Binding Factors 1 and 2 (TRF1 and TRF2) are both homodimers that 
bind telomeric duplex DNA with the C-terminal Myb domains(50). Together the two proteins 
help create the t-loop/D-loop structure. TRF1, because of its highly flexible TRFH dimerization 
domain(51), can bind duplex telomeric DNA at two sites that are far apart from each other(52), 
causing the telomeric DNA to bend back on itself(53;54). With TRF1 inducing of t-loop 
formation, the role of creating the D-loop falls to TRF2.  In addition to the Myb domain that is 
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nearly identical to the TRF1 Myb domain(55), TRF2 possesses an N-terminal basic (B) domain 
which binds to HJ DNA regardless of sequence(56), catalyzing the formation of the t-loop when 
the 3’ tail is at least six nucleotides long(57). TRF2 recruits RAP1 to the telomere, which confers 
protection against unwanted non-homologous end joining (NHEJ) at the telomeres(58). NHEJ is 
a DNA damange repair pathway that repairs double-stranded breaks in DNA, and which causes 
chromosomal fusions if active against telomeres. TRF1 negatively regulates the telomere 
length(59). The sixth shelterin protein, TRF2 Interacting Factor 2 (TIN2) (60), binds not only to 
TRF1 and TRF2(61) but also to POT1, coordinating between ssDNA-binding and duplex-
binding shelterin proteins (1).  
 
1.3.3 Alternative DNA structures at the open telomere conformation 
The G-rich TTAGGG repeats of the 3’ tail can form G-Quadruplex DNA (G4 DNA), a 
pseudoknot formed by the Hoogsteen base-pairing of four guanine residues into a planar tetrad 
(Fig. 1.4A)(62). In the case of human telomeric DNA, four telomeric repeats will form G4 DNA 
with three stacked tetrads stabilized by an anion (Fig 1.4B). The TTA repeats act as linkers 
between the planar tetrads; the precise topology of the linkers can vary greatly depending on 
anions(63;64), crowding conditions, and the presence of flanking DNA(65), among other factors. 
G4 DNA can form at the 3’ tail of the telomere in the telomere open conformation or in the 
displaced G-rich DNA in the D-loop in the telomere closed conformation. Telomeric G4 DNA 
been detected in S. lemnae telomeres using immunofluorescence(66). Outside of the telomeres, 
G4 DNA has been observed with electron microscopy in the non-coding G-rich strands of 
transcription bubbles(67)  
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Structural studies of G4 DNA have focused on individual G4s, including all Protein Data 
Bank (PDB) files from Nuclear Magnetic Resonance (NMR) and X-ray crystallography (e.g., 
(62;63;68-71)). However, since the human telomere may have up to 30 telomeric repeats(1), 
multiple quadruplexes may fold, and might even fold “stacked” structures of multiple tetrads(72) 
that form a rigid structure similar to the guanine-wire (G-wire), which is a long nanowire 
composed of intermolecular G-tetrads(73).  
The structure of G quadruplexes on long telomeric tails has important implications for the 
structure of the chromosome. A recent study demonstrated that G4 DNA formation promotes 
telomerase activity in yeast (74).Telomere End Binding Protein β (TEBPβ, the homolog of the 
TPP1) facilitates the formation of G4 DNA in Oxytricha nova(75). While the function does not 
exist in human TPP1, quadruplexes are functionally vital in gene promoter sites(76) and as a 
telomerase promoter in fission yeast (74), suggesting that quadruplexes may have both desirable 
as well as harmful effects on the telomeric homeostasis. 
While no quantitative structural studies of long telomeric tails exist, bulk studies have 
suggested that individual quadruplexes form as “beads on a string” (Fig. 1.5) on long telomeric 
tails rather than the rigid stacked formation. Melting studies demonstrated that telomeric tails 
with telomeric repeats in integer multiples of four (e.g., 8, 12, 16) had comparable 
thermodynamic stabilities, with non-integer multiples being less stable(72). However, another 
study that used potassium phosphate buffer instead of Tris found that longer telomeres were 
progressively less stable due to enthalpic penalties (77).  
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Fig. 1.4  Structure of human telomeric G4 DNA. A, an individual tetrad of four guanines bound 
by Hoogsteen base-pairing with each other. B, the human G quadruplex structure elucidated by 
NMR, with the flat, planar guanine tetrads visible in the middle in red. Adenine and thymine 
loop residues are in blue. Both subfigures are from structure 2JPZ (65), accessed from the 
Protein Data Bank (www.pdb.org) and depicted using VMD (University of Illinois Urbana, 
Illinois). 
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Fig. 1.5. Proposed model of a beads on a string arrangement of two quadruplexes. Two copies of 
the 2JPZ structures from Fig. 1.4 were linked together using Pymol after removing the two 3’ 
thymines from the upstream quadruplex. Note the two peaks separated by the central gap 
between the quadruplexes. 
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The UV melting data demonstrating the stability bonus of having a multiple of four telomeric 
repeats also suggested that quadruplexes fold in such a way that they maximize the number of 
quadruplexes formed (e.g., three quadruplexes on 12 telomeric repeats) (78).  However, recent 
circular dichroism (CD) studies on a (TTAGGG)13
 
 substrate showed that titrations of a 
quadruplex-loop binding molecule indicated that only two quadruplexes formed(79). Since these 
values are only averages of bulk populations, the makeup of a molecular population with G4 
forming potential is still unknown, although they are functionally relevant to the extended or 
open telomeric tail telomere conformation. 
1.3.4 Alternative DNA structures at the closed telomere conformation 
A linear chromosome must hide its ends from the DNA repair machinery of the cell.  The 3' 
ssDNA tail provides an elegant solution to this problem by invading the upstream duplex 
telomeric DNA and creating the D-loop portion of the t-loop/D-loop structure. This strand 
invasion is catalyzed by the shelterin protein TRF2, a homodimer that has two binding sites on 
each monomer. The N-terminal B domain binds HJ DNA centers in a sequence independent 
manner(56),  and the C-terminal Myb domain specifically binds duplex telomeric DNA(55). 
TRF2, but not TRF1, catalyzes strand invasion via the N-terminal domain by inducing positive 
supercoils in the duplex telomeric DNA(57). Similar to HJs, a replication fork may stall, causing 
the newly synthesized strands to anneal to each other, peeling away from the templace strands.  
This regressed replication fork or “chickenfoot” structure is a possible site for TRF2 binding, as 
telomeric replication forks are prone to regression (80).  
TRF2 maintains telomeric integrity via three chief pathways, the first being the 
suppression of the ataxia telangiectasia mutated protein (ATM) pathway of double strand break 
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repair by binding the RAP1 shelterin protein. TRF2 itself does not suppress the ATM pathway 
but rather mediates ATM suppression by recruiting RAP1 to the telomere(81). TRF2 also 
protects the telomere D-loop/t-loop structure from HJ cleavage via its N-terminal, Basic (B) 
Domain, which bind HJ centers regardless of sequence (82). If a deletion mutation of TRF2 
missing the B domain (TRF2ΔB) is expressed in a cell, telomeres undergo sudden shortening 
with telomeric circles appearing in both 2D electrophoresis and electron micrographs(37). The 
phenotype is suppressed when the X-Ray Cross Complentation 3 (XRCC3) homologous 
recombination protein is deleted, indicating that HJ cleavage is the cause for sudden telomere 
shortening(37). In WS cells, however, TRF2ΔB expression does not cause sudden telomere 
shortening from HJ cleavage activity, possibly because TRF2 prevents WRN from catalyzing the 
branch migration of a D-loop into a full HJ that can be cleaved(83). 
The mechanism of TRF2 in stabilizing HJ DNA at the telomere has been partly 
characterized by biochemists. Poulet and colleagues have shown that the B domain of TRF2 is 
necessary to protect an artificial HJ against the HJ cleaving enzyme XPG-like endonuclease 
(GEN1)  in vitro(84). No similar biochemical studies, however, have examined how TRF2 
modulates WRN activity on HJ DNA in vitro. Since TRF2 stimulates WRN activity on telomeric 
duplex DNA, it is not obvious that TRF2 necessarily would inhibit WRN-mediated displacement 
of HJ DNA. 
 WRN is not the only helicase that can be deleterious if it is not tightly regulated by the 
shelterin complex. In fission yeast, the WRN homolog Rqh1 causes telomere loss if the TRF1/2 
homolog Taz1 and the DNA-binding protein RPA is deficient(85). Mutating SUMOylation sites 
in Rqh1 in the absence of functional Taz1 leads to telomere loss and hyperrecombination and 
inter-chromosomal telomeric entanglements(86). Elucidating the mechanism of WRN regulation 
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by TRF2 would provide an important contribution to the body of knowledge on how telomeric 
DNA structures are maintained by the shelterin complex. 
 
1.4 SINGLE MOLECULE ATOMIC FORCE MICROSCOPY IMAGING 
Atomic Force Microscopy (AFM) uses minute deflections in a thin needle (tip radius is under 10 
nm) to record a topographical map of molecules deposited on an ultraflat surface. The two 
primary modes of AFM are contact or tapping (reviewed in (87;88)). In the former, the tip is kept 
at a certain height above the surface. When the tip is deflected by a surface feature, the feedback 
mechanism in the AFM moves the tip so that it will be at the preset height. These deflections are 
used to calculate the height of the surface at a given x-y coordinate to build up an image of the 
surface. In the tapping mode, the tip oscillates at a set amplitude of vibration, which is altered 
when the tip approaches an object. A feedback loop similarly adjusts the height of the tip to 
maintain the amplitude of vibration. The modulations in the tip’s frequency are then used to 
reconstruct the proximity, and thus, the height of an object. The tapping mode is less direct and 
thus, preferred for biomolecules, which can be distorted by direct contact. AFM may be done on 
a dry sample in the air, or it may be done in a fluid-filled container, the latter being more 
complicated but permitting one to study live cells and protein dynamics(87). This introduction 
will focus on the air AFM method. 
Because AFM can identify individual molecules at the nanometer scale, it is excellent at 
distinguishing diverse molecular conformations. AFM has been successfully employed to 
quantify single stranded, duplex and triple-stranded DNA(89), Holliday Junctions(90;91) and 
processing of DNA by DNA repair enzymes(92;93). While there have been AFM studies of G4 
DNA, these focused on non-telomeric sequences(94) and single telomeric quadruplexes(95), and 
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the limited studies that did  involve telomeric DNA were not quantitative(96;97). AFM is well 
suited for studies on long telomeric ssDNA substrates, where multiple G4 conformations and 
POT1 binding registers are possible. 
While the bulk data on G4 DNA are valuable, quadruplexes are a difficult subject for 
bulk studies since they are dynamic structures that may spontaneously fold and unfold(64). 
Moreover, the topology of the loops in between G4 tetrads and their orientations are highly 
dependent on the concentration of the DNA, the cation used and its concentration (63;64), 
flanking sequences(65), and the presence or absence of crowding agents(95;98), to name some 
primary examples.  
Important data on single quadruplexes have come from single molecule Foerster 
Resonance Energy Transfer (FRET), demonstrating the role of cations and temperature on 
quadruplex stability and loop orientation(64). FRET employs a donor and an acceptor dye pair 
where the excitation spectrum of the acceptor overlaps with the emission spectrum of the donor. 
Therefore excitation of the donor dye will result in the excitation and emission of the acceptor by 
an induced dipole, with the amplitude of the acceptor dye being in inverse proportion of the 
distance from the donor, creating a molecular ruler in real time(99).  However, a longer substrate 
with multiple possible folding G4 conformations does not lend itself to FRET studies since one 
would require a prohibitive number of substrates with different dye pairs. Atomic force 
microscopy has the advantage of studying individual molecules like FRET but by visualizing the 
shapes of individual molecules (rather than the distance between two dyes molecules), AFM 
produces a more detailed picture of DNA folding than FRET. Unlike bulks studies, AFM does 
not measure an average value but permits a whole range of conformations to be individually 
inspected and quantified. 
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1.5 STATEMENT OF THE PROBLEM 
Telomeric instability is correlated with age-related diseases and tissue dysfunction (3). The 
stability of a telomere is maintained by a shelterin complex of six proteins at the telomere plus 
numerous shelterin and telomere accessory proteins like WRN and p53 (1).  Many of the 
accessory proteins can be deleterious to telomeres if they are not regulated by the shelterin 
proteins. In addition to the proteins interactions, non-canonical DNA structures like HJs and G4 
DNA add further layers of complexity in telomere function and dysfunction. We hypothesize that 
alternate structures of DNA exist in dynamic equilibrium in telomeric DNA and the equilibrium 
is modulated by WRN helicase/exonuclease in cooperation with telomere-binding proteins.    
The first goal is to determine the ability of WRN and POT1 to modulate G4 formation on 
long physiologically relevant telomeric ssDNA tails. Most studies have focused on individual 
quadruplexes, but physiologically relevant telomeric DNA lengths can fold into multiple 
quadruplex arrangements. Furthermore, studies on long telomeric substrates have largely 
consisted of bulk experiments, measuring the mean values of what could be a highly 
heterogeneous population. The second goal is to elucidate the modulation of Holliday-Junction 
dynamics by TRF2 and WRN. We developed fluorophore imagery to track WRN processing of 
HJ DNA containing differing arrangements of telomeric repeats with and without TRF2 and/or 
the TRF2-binding protein RAP1.  
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1.6 OUTLINE OF THESIS 
 
Chapter 1 is a general introduction to telomere homeostasis and the value of the progeroid 
disease Werner Syndome as a model telomeric pathways of aging. The structure and function of 
the Werner helicase/exonuclease (WRN) will be introduced, and then discussed in the context of 
modulating DNA structures in the open and closed conformations of the telomere. The shelterin 
complex of telomeric proteins will be then introduced and their interactions with each other and 
their modulation of DNA structures will be discussed. Finally, the Atomic Force Microscope and 
its role in single molecule biology will be reviewed. 
Chapter 2 describes the characterization of G quadruplex (G4 DNA) formation on 
physiologically realistic telomeric tails by AFM imagery, and the destabilization of G4 DNA by 
the POT1 proteins. 
Chapter 3 discusses the elucidation of the role of TRF2 in protecting telomeric Holliday 
Junctions against unwanted WRN helicase/exonuclease activity. The mechanism of HJ 
displacement by WRN is analyzed and discussed in the context of interactions with TRF2 at the 
telomere. 
Chapter 4 provides an overview of the experimental results and an analysis of some of the 
limitations of the AFM system in visualizing the G4 DNA system in Chapter 2. Further avenues 
of research using both AFM and single molecule Förster Resonance Energy Transfer (FRET) are 
discussed.  
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2.0 STRUCTURE OF G-QUADRUPLEX ASSEMBLIES ON LONG TELOMERIC 
SINGLE STRANDED MOLECULES IS MODULATED BY POT1 
 
This chapter is currently being prepared as a manuscript by the following authors: Hong 
Wang†, Gerald J. Nora†, Harshad Ghodke, Bennett Van Houten, and Patricia L. Opresko.  
†
 
These authors contributed equally to the paper. H.W. and G.J.N. proposed the project, 
designed and performed most of the experiments, analyzed the data, and wrote the manuscript; 
H.G. performed some of the AFM experiments; P.L.O. supervised the project, interpreted the 
data and wrote the manuscript.  
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2.1 INTRODUCTION 
Cells with linear chromosomes must solve two problems: the progressive lagging-strand 
shortening with each cycle of DNA replication and the need to protect the ends of linear 
chromosomes from unwanted DNA damage responses(1). The telomere is a solution to both 
these problems and stands at the junction between aging, genomic stability and cancer. 
Telomeres are composed of the “shelterin complex” of proteins and TTAGGG repeats of duplex 
DNA along with  an ssDNA overhang or “tail” of 50-500 nucleotides(1). The ssDNA tail can 
fold into G-quadruplex (G4) DNA, which consists of three tetrads of four guanines that form 
Hoogsteen base pairs with each other (Fig. 2.1A). These tetrads are in a square-planar 
conformation and are stacked atop one another with the TTA sequences forming linker 
loops(100;101). The formation of G4 DNA has been shown to inhibit the telomere-lengthening 
enzyme complex telomerase in vitro(102), although a recent in vivo study of S. cerevisiae 
telomerase found that G4 DNA can promote the activity of yeast telomerase(74).  
The folding of G4 DNA is inhibited when the DNA is bound by the protection of 
telomeres 1 (POT1) protein(103), which is part of the shelterin complex of proteins that bind, 
protect and regulate telomere structure and function. The mechanisms underlying the POT1 
modulation of intra-molecular G4 DNA assembly on physiologically relevant telomeric ssDNA 
tails in which multiple G4 DNA structures are possible, are unknown. Studying POT1 loading on 
physiological telomeric tails is complicated by a lack of data on G4 DNA formation on long 
ssDNA strands.  X-ray crystallographic and NMR studies of G4 DNA have focused on 
individual quadruplexes formed from four TTAGGG repeats(62;63;68-71). Since the telomeric 
tail may have upwards of 30 such repeats(1), it is important to  understand the arrangements of 
quadruplexes, and how many quadruplexes can form on longer telomeric ssDNA.  Results from 
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thermal melting assays support the hypothesis that longer telomeric repeats form a beads-on-a-
string G4 assembly  in which individual quadruplexes are separated from each other by a TTA 
linker (Fig. 2.1B)(78), although some data and extrapolations from an NMR structure support a 
“stacked” arrangement of quadruplexes(104;105). 
Atomic force microscopy (AFM) offers a single-molecule approach that allows one to 
examine distinct nucleic acid structures (single-, double- and triple-stranded) and their 
distribution within a heterogeneous population(106;107).  In addition, previous AFM studies 
established the visualization of single human telomeric G4 DNA by AFM(95).  However, the 
quantitative distribution of various quadruplex numbers and arrangement ensembles of 
individual molecules within a potentially very heterogenous population of long single-stranded 
telomeric molecules have not been addressed. Even more importantly, POT1 coats the 3’ ssDNA 
tail of the telomere(108;109), and POT1 can greatly influence the distribution of G4 structures 
within a population of telomeric DNA. However, modulation of G4 folding by POT1 on 
physiologically relevant telomeric tails has not been investigated at the single-molecule level.   
AFM has been used extensively in studying protein-DNA interactions(110;111), validating its 
application in visualization of the modulation of the telomeric tail structure by POT1.  
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Fig. 2.1 Base pairing in G4 DNA and schematic of beads-on-a-string model. (A) Planar tetrad of 
guanines bound by Hoogsteen base pairing. Image created on VMD (Urbana, Illinois) using the 
Protein Bank 2JPZ structure(104).
 
 (B) Schematic illustration of the beads-on-a-string model(62). 
In this model, long single stranded telomeric DNA form a beads-on-a-string G4 assembly in 
which individual quadruplexes are connected with each other by an ssDNA linker. 
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 First, to study the formation of G4 DNA on realistic telomeric tails, we performed 
single-molecule AFM imaging of defined DNA substrates with a duplex stem followed by single 
stranded TTAGGG repeats (4, 8 or 16), and conducted detailed quantitative analysis of the 
length, height, and volume of the G4 structures.  At physiological salt concentrations, 55%  of 
(TTAGGG)16
 
 molecules formed only two G4 structures consistent with a beads-on-a-string 
conformation, instead of the maximum of four that would occur if all the TTAGGG repeats 
folded into quadruplexes. Secondly, we found that POT1 is a monomer with a height differing 
from G4 DNA under AFM imaging conditions. POT1 can coexist with G4 DNA on the same 3’ 
tail and shift the population distribution toward molecules that have half the number of G4 units 
as substrates without POT1, or that are completely unfolded. These novel results provide a 
structural basis for the dynamic interplay between G4 DNA formation/disruption and POT1 
binding at the telomeric 3’tails. 
2.2 RESULTS 
2.2.1 Long telomeric tails are underfolded 
Prior to studying POT1 modulation of G4 DNA on physiological telomere tails, we set out to 
elucidate G4 DNA structures on these molecules in the absence of POT1. Previous AFM studies 
of G4 DNA used either short telomeric sequence (four repeats), 3’ tails of unknown lengths, or 
did not provide quantitative or distribution analysis of the images(112-114). Consequently, 
detailed information regarding the distribution and types of conformations of physiological 
telomeric tails required further study. We designed a series of defined DNA substrates which 
have a 34 bp duplex stem at the 5’ end followed by a 3’ ssDNA overhang of 4, 8 or 16 TTAGGG 
repeats (Tel4, Tel8 and Tel16, respectively, Table 2.1).  Tel4, Tel8 and Tel16 can potentially 
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form a maximum of 1, 2, and 4 G4 units, respectively. We reasoned that comparison of G4 
structures formed on these substrates as visualized through AFM imaging, would provide 
quantitative information regarding the number of G4 units present on each molecule. AFM field 
view images and surface plots of Tel4, Tel8 and Tel16 show that all three telomeric substrates 
formed structures with heights between 1 and 2 nm (Figs. 2.2,2.3, an d 2.8), which were not 
observed in images of duplex DNA or an ssDNA substrate which lacks G4 forming sequences 
(Figs. 2.8 and 2.2E, respectively). The heights of peaks observed for the Tel4, Tel8 and Tel16 
substrates are consistent with the height measurements from previous AFM studies of G4 
DNA(115).  
Since the height of G4 structures (average height, 1.32 ± 0.22 nm) exceeds the  height of 
duplex DNA (0.61 ± 0.1 nm, Fig. 1D), we measured the length of G4 structures at 1 nm height 
(Fig. 3 ) to compare the amount of G4 DNA formed on Tel4, Tel8 and Tel16. In addition, we 
measured the volumes of G4 DNA derived from the AFM images. AFM-derived volume has 
been used extensively to study the oligomerization states of globular proteins and protein-protein 
interactions(110;116). The lengths (at 1 nm height) and volumes of Tel4, Tel8 and Tel16 are 
shown in Figs. 2.2D and 2.8, respectively. The mean lengths of G4 DNA at 1 nm height of Tel4 
and Tel8 are 12.5 (± 1 nm, 3 depositions) and 15 (± 3 nm, 3 depositions) nm, respectively. The 
mean length of Tel8 is slightly longer than Tel4, but is not doubled as would have been expected 
if Tel8 formed the maximum possible number of quadruplexes. All Tel16 molecules in the AFM 
images displayed peak heights greater than 1 nm (Fig. 2.3C). The mean length of Tel16 (22 ± 2 
nm, 3 depositions) is only approximately twice that of Tel4, even though Tel16 could 
theoretically form a maximum of four repeats 
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Figure  2.2   
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Fig. 2.2 Quantification of the number of G4 structures formed on Tel4, Tel8 and Tel16. (A-C) 
Schematic drawings and representative AFM surface plots of Tel4 (A), Tel8 (B) and Tel16 (C) 
DNA substrates. Thin arrows point to single G4 structures and wide arrows denote two distinct 
G4 structures on individual Tel8 or Tel16 molecules. The sequences of the substrates are shown 
in Supplementary Table 1. All DNA substrates were incubated in a buffer containing 150 mM 
KCl and deposited at 500 nM concentration (see Methods). Minor particles in A are likely 
contaminants in the Tel4 preparation, such as acrylamide from the gel purification by the 
manufacture, rather than unfolded molecules since these images differ from unfolded Ctrl16 
structures. (D) The histogram of G4 length (cross-section at 1 nm height) measured from AFM 
images of Tel4 (open bars, n=374 molecules), Tel8 (gray bars, n=299 molecules) and Tel16 
(black bars, n=288 molecules). The dotted lines are Gaussian fits to the data. (E) A 
representative AFM surface plot of Ctrl16 DNA, which contains 8 TTAGGGTTAGTG repeats 
(Table 2.1) and does not form G4 structures. The triangle points to an individual Ctrl16 
molecule. All images are 500 nm × 500 nm at 2 nm height scale. 
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Figure 2.3    
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Fig. 2.3 Subpopulation of Tel16 molecules resembles beads-on-a-string. A representative AFM 
image (left panel) and sectional analysis (right panel) of a Tel16 molecule in which individual 
G4 structures cannot be resolved (A) and a Tel16 molecule which contains two distinct peaks 
(B).  (C) A representative image of a Tel16 molecule with three distinct peaks. The AFM images 
are 250 nm × 250 nm at 2 nm height scale. The white lines in AFM images indicate the lines 
drawn for section analysis. The solid lines with arrows in the section analysis indicate the length 
of G4 measured at 1 nm height; the dashed lines with arrows indicate the interpeak distances. 
The number at the top right corner of each image indicates the percentage of each type of 
molecules observed in the total population of Tel16 molecules. 
 
 
 
 
 
 
 
 
 
 
 
 
 32 
To investigate the mechanism underlying the underfolding (i.e. formation of less than the 
maximum potential number of quadruplexes) of Tel8 and Tel16, we constructed a first-principles 
combinatoric model (see Methods) considering each telomeric repeat as a lattice point which 
can either be extended or folded into G4 DNA (Fig. 2.4A). The model shows that the formation 
of a single G4 in Tel8 is nearly five times more probable than two G4 structures (calculated in 
Methods). For Tel16, the most striking insight from the combinatoric model is that formation of 
four G4 structures on Tel16 is a rare event, which is consistent with our experimental data.   In 
addition, the folding of two quadruplexes was the most probable conformation (Fig. 4B),  but 
three quadruplexes were almost as probable as two.  This did not fit the normalized experimental 
data in which the lengths of G4 regions from Fig. 1 were divided by the mean G4 length (12.5 
nm) from the Tel4 data (Fig. 2.4B). A previous study reported indirect evidence that an 
oligonucleotide with 13 telomeric repeats formed only two quadruplexes(79).  Assessing whether 
or not the combinatoric model is consistent with the results using 13 telomeric repeats, we 
calculated the probability distributions for DNA containing 13, 14 and 15 repeats. 
We found that both substrates with 13 and 14 repeats  both exhibited maxima for two G4s, but 
for a molecule with 15 repeats, three G4s was highly probable as well (Fig. 2.4B).  
2.2.2 Long telomeric tails form beads-on-a-string structures 
Different models have been proposed to describe the intra-molecular assembly of multiple G4 
units on long telomeric ssDNA(78;117;118).  In a beads-on-a-string model, two G4 units are 
connected by one linker without stacking interactions between the units (Fig. 2.1B). In the 
stacking model, every G4 unit stacks onto adjacent G4, with residues on the TTA loops 
interacting with each other(78;105;119). 
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Fig. 2.4 Longer telomeric tails rarely form the maximum potential number of quadruplexes. (A) 
Schematic examples and calculations of the number of possible arrangements of G4 DNA on 
Tel16 (see Methods for equation). (B) Probability of forming 1, 2, 3 and 4 G4 structures on 
substrates with 13, 14, 15, and 16 (Tel13-16, respectively) based on the combinatoric 
calculations detailed in Methods. The Tel16 data curve is based on the length of G4 regions on 
Tel16 molecules normalized using the length of single G4 measured from AFM images of Tel4 
(12.5 nm).  
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Among all the Tel16 molecules observed, 23% displayed two distinct peaks in the AFM 
images (Figs. 3B). The mean interpeak distance of Tel16 molecules with two distinct peaks is 20 
nm, which corresponds to ~7 TTAGGG repeats between the individual quadruplexes (Fig. 2.12). 
In the AFM images of Tel16 molecules, a small population (1%) of molecules exhibited as many 
as three distinct peaks (Fig. 2.3C).  The assembly of multiple defined peaks resembles individual 
beads-on-a-string. It is worth noting that due to limitations in the AFM resolution, results from 
AFM imaging could underestimate the number of Tel16 molecules forming beads-on-a-string 
structure (see calculations in Chapter 4.1). 
To further differentiate between the beads-on-a-string and the stacking models, we 
imaged G-wires which are long complexes of highly ordered self-assembly of inter-molecular 
G4 units (Fig. 2.5A). G-wires are notable for reliably creating long, uniform quadruplectic 
structures with heights greater than 1 nm(120). AFM images of G-wires formed by the short 
oligonucleotides G4T2G4 are shown in Figs. 5B and 5C.  
stacking of the adjacent G4 units, as expected, regular well separated peaks were not apparent in 
the AFM images as expected, even for G-wires that were the same length as Tel16 molecules 
(Fig. 2.5C,D).  In addition, G-wires exhibited a statistically significant (p < 0.008) greater 
average height (1.63 ± 0.17 nm) compared to the Tel16 structures (1.32 ± 0.22 nm) (Fig. 2.6B). 
These results suggest that the G-wires appeared to be more rigid possibly due to the direct 
stacking interactions between adjacent G4 units, which lead to less compression by the 
mechanical AFM imaging process. The distinctly different structure and stiffness of the G-wires 
compared to the Tel16 molecules revealed by AFM imaging suggest that G4 structures on Tel16 
molecules are inconsistent with a stacked model of multiple G4 units. 
Since the G-wires involve  
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Fig. 2.5 AFM imaging of G-wires reveals a smooth surface without distinct peaks. (A) Proposed 
model for G-wire formation. (B) An AFM field view image of G-wires. The image is 1 μm × 1 
μm at 2 nm height scale. (C) An AFM surface plot of G-wires. The AFM surface plot is 250 nm 
× 250 nm at 2 nm height scale. The white line denotes the line for section analysis.  (D) Section 
analysis of G-wire highlighted in (C).    
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2.2.3 Oligomeric state of POT1 
A key issue in understanding the mechanism of action by POT1 is its oligomeric state. Despite 
evidence showing a monomeric state for the N-terminal domains of human POT1(121), 
information on the oligomeric state of full length human POT1 proteins was lacking. To evaluate 
the oligomeric state of full length POT1 we measured the volume of POT1 in AFM images 
compared to other known proteins of various sizes. AFM-derived volumes of proteins can be 
correlated to their molecular masses, permitting determination of oligomeric states (see 
Methods) and protein-protein interactions(122).  Purified POT1 protein after removal of the 
GST-tag appeared as monodispersed particles in the AFM images (Fig. 2.7A).The distributionof 
the calculated AFM-derived volumes of POT1 is Gaussian and centered at ~22 nm3
 
, which is 
consistent with the expected value for a POT1 monomer based on our calibration curve for 
globular proteins (Fig. 2.14).  These results demonstrate that POT1 exists as a monomer in 
solution under the AFM imaging conditions tested. In contrast, AFM images of GST tagged 
POT1 protein (GST-POT1) revealed particles larger than untagged POT1 protein (Fig. 2.8A ). 
Statistical analysis of the AFM-derived volume of GST-POT1 indicated a distribution consistent 
with the presence of GST-POT1 dimers and tetramers (Fig. 2.8B). These results demonstrate that 
the GST tag can artificially force POT1 to form dimers and higher order oligomers.  Therefore, 
only untagged POT1 was used in all the imaging experiments with the DNA substrates. 
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Fig. 2.6 Height as a function of amplitude and substrate. (A) The height of hemagglutinin (HA) 
antibody in AFM images as a function of target amplitude. Monoclonal HA antibody (50 nM, 
Covance) was deposited onto mica and imaged under standard conditions (Methods). To 
generate each data point, the same area of the mica surface was imaged and the average height of 
60 HA antibody molecules was calculated, for each value of the target amplitude for the 
Nanoscope V. Each error bar represents one standard deviation in the height. It is worth noting 
that the measured height is maximum at 300 mV. This is because in the low target amplitude 
regime, the background noise tends to be high leading to a lower corrected height whereas at 
higher target amplitudes, the force exerted on the molecules is sufficiently large to cause 
significant compression of the molecule, leading to a reduced measurement of the height. (B) 
Box plot of AFM average heights of all the molecules in AFM images of POT1 only (n=1262 
molecules), POT1 in the presence of Ctrl16 (n=304 molecules), Tel16 only (n=235 molecules) 
and G-wire (n=444 molecules). The image background height is at 0.3 ± 0.05 nm. The height 
measurements were done using Image SXM software as described in Methods. Each box 
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represents the interquartile range (25th to 75th
 
 percentiles).  The horizontal bars in the boxes 
represent the medians. The vertical bars represent the range of values included in the statistics, 
from the maximal to the minimal.   
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2.2.4 POT1 binding competes with G4 formation  
To study the binding of POT1 to physiological telomeric tails using AFM we utilized two DNA 
substrates, Tel16 and Ctrl16 (Table 2.1). Ctrl16 has the same length as the Tel16 DNA substrate, 
but every other TTAGGG sequence in Ctrl16 is changed to TTAGTG, which eliminates G4 
folding (Fig. 2.2E)(123), but preserves POT1 binding(1). Accordingly, both Tel16 and Ctrl16 
substrates have a maximum of eight POT1 DNA binding sites. Electrophoresis mobility shift 
assays (EMSA) showed that under the same conditions POT1 binds Tel16 and Ctrl16 substrates 
to a similar extent (Fig. 2.9).  The appearance of more than one shifted band suggests that 
multiple POT1 molecules can bind to the Tel16 or Ctrl16 substrates. In the AFM images of 
Ctr16 with POT1, arrays of tandem POT1 proteins were observed (thin arrow, Fig. 2.10A and 
C), which were not present in the POT1 alone images (Fig. 2.7A). The mean height of these 
POT1 arrays is 0.83 (± 0.15) nm which is comparable to the POT1 height (0.71 ± 0.11 nm) in 
protein alone images.  The statistically significant height difference (p < 0.004) between POT1 
(0.83 ± 0.15 nm, on Ctrl16) and G4 DNA on Tel16 (1.32 ± 0 .22 nm), (compare Figs. 2.3,2.6,and 
2.7A,) is due to the increased stiffness of G4 DNA compared to POT1 protein, which leads to 
less compression by the mechanical AFM  imaging process. Accordingly, the distinct heights of 
POT1 and Tel16 in the AFM images provide a robust criterion to differentiate between POT1 
and G4 structure when POT1 and Tel16 are mixed together (Fig. 2.6B). Previously, AFM height 
measurement has been used to differentiate a DNA repair protein UvrB and a UvrB-quantum dot 
conjugate(111) 
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Fig. 2.7 Full length POT1 is a monomer in solution. (A) A representative AFM image of 
untagged POT1 protein at 200 nM concentration. The image is 1 μm × 1 μm at 2 nm height 
scale. (B) AFM volume distribution of POT1 from images of POT1 at 200 nM concentration. 
The dashed line represents the Gaussian fit to the data (n=664 molecules, R2= 0.96), which is 
centered at 22 nm3
 
 and corresponds to POT1 monomer based on the standard calibration curve 
(Fig. 2.14).   
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Fig. 2.8 AFM image and volume analysis of GST-POT1. (A) Representative AFM image of 
GST-POT1 protein at 20 nM concentration. The image size is at 1 μm × 1 μm. (B) AFM volume 
distribution of GST-POT1. 
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Fig. 2.9  Gel-shift assay of POT1 binding. (A) Schematic drawing of the DNA substrates for 
EMSA. The sequences of Tel16 and Ctrl16 are shown in Supplementary Table 1. The green 
circles represent 3’ fluorescein adducted thymine. (B) EMSA assay of POT1 binding to Tel16 
and Ctrl16 substrates.  POT1 at indicated concentrations was incubated with Tel16 or Ctrl16 at 
10 nM in 1X POT1 buffer at 37 oC for 15 minutes. Half of each reaction was removed 
immediately and loaded onto a 1% agarose gel and was subject to electrophoresis at 10 V/cm in 
1X TBE buffer for 1 hour at 4 °C. The gel was scanned using a TyphoonTM 9400 VariableMode 
Imager.  
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When 200 nM POT1 was incubated with Tel16 (1 μM) the percent of molecules that 
exhibited structures with G4 DNA character (height > 1 nm) was greatly reduced from 100% of 
the measured molecules of Tel16 alone to 24% (98/410) of the molecules visualized after co-
incubating Tel16 with POT1 (Fig. 2.10B), and the majority of molecules (77%, 330/405) showed 
only structures that were characteristic of bound POT1. Importantly, of the G4 DNA structures 
observed (98/410), 23 molecules displayed multiple peaks with differing heights that were 
consistent with G4 DNA and bound POT1 on the same molecule (compare Fig. 2.10C with D).  
These images indicate that G4 DNA and POT1 can coexist on the same molecule.  Moreover, the 
lengths of the G4 regions remaining after POT1 addition were less than half of the G4 region 
lengths on Tel16 alone (Fig. 2.10E), consistent with a POT1-mediated shift from two to one G4 
units on each individual Tel16 molecule.  It is also worth noting that the bound POT1 region 
length distributions for Ctrl16 and Tel16 (Fig. 2.10F) were  very similar in that both exhibited a 
long right-sided “tail” representing similar numbers of POT1 proteins bound to Tel16 and Ctrl16 
molecules.  The length of longer POT1 arrays (45 to 60 nm) is consistent with the length of 
ssDNA (48 nm, assuming ssDNA as 0.5 nm/base) on fully extended Tel16 (Fig. 2.10F). 
Together, these data indicate that POT1 binding can successfully compete with G4 DNA folding 
on telomeric ssDNA.  
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Figure 2.10 
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Fig. 2.10 POT1 competes with G4 DNA folding on 3’ telomeric tails. (A) A representative AFM 
surface plot of Ctrl16 (1 μM) in the presence of POT1 (200 nM). (B) A representative AFM 
surface plot of Tel16 (1 μM) in the presence of POT1 (200 nM).  The AFM images are 350 nm × 
350 nm at 2 nm height scale. The triangles point to individual POT1 molecules. The thin arrows 
point to representative structures with multiple POT1 proteins. The thick arrow points to a 
representative structure with folded G4. Dotted lines denote molecules whose cross-sections are 
shown in C and D. (C) Cross section of molecule highlighted in A showing two POT1 molecules 
on the same telomeric tail. (D) Cross-section of molecule highlighted in B demonstrating that G4 
(left) and POT1 (right) coexist on the same molecule. (E) Histogram of the length of G4 DNA 
regions (stretch of DNA with height taller than 1 nm) measured from AFM images of Tel16 
alone (black bar) and Tel16 (1 μM) in the presence of POT1 (200 nM, open bar). (F) Histogram 
of the length of POT1 regions (stretch of structure feature with height between 0.5 and 1 nm) 
measured from AFM images of POT1 alone (200 nM, open bars; n=51 molecules), in the 
presence of Ctrl16 (1 μM, gray bars; n=103), and Tel16 (1 μM, black bars; n=330 molecules). 
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2.3 DISCUSSION 
POT1 binding to (TTAGGG)4 substrates prevents G4 DNA folding(103;124).  However, the 
arrangement of G4 DNA and the competition with POT1 binding on a long, physiologically 
realistic telomeric substrate was unknown. In this study we used single-molecule imaging to 
examine the assembly of G4 units on DNA substrates containing 4 (Tel4), 8 (Tel8) and 16 
(Tel16) TTAGGG repeats, with the latter representing the mid range of the telomeric overhang 
length in human cells(1). Telomeric DNA with well-defined lengths allowed us to study the 
length dependent formation of G4 structures at the single-molecule level. We demonstrated that 
G4 DNA assemblies on physiologically relevant telomeric tails rarely form the maximum 
potential number of G4 units, and G4s are arranged in a beads-on-a-string conformation. This 
study is the first to show via AFM imaging that POT1 is monomeric and stabilizes the ssDNA, 
driving the (TTAGGG)16
The AFM imaging results from this study indicate that the majority of telomeric tails at 
lengths that occur in human cells did not fold into the maximum potential number of G4 units. 
The structure length and volume measurement comparison with Tel4, which can only form one 
G4 unit, indicates that the Tel8 and Tel16 molecules primarily fold into one and two G4 units, 
respectively (Fig. 2.2D and 2.8). We applied a first principles combinatoric approach to 
understand the mechanism underlying the underfolding, and found that the prediction from this 
model for ssDNA with 13 repeats (Fig. 2.4B) is consistent with a bulk circular dichoism study of 
 structural equilibrium towards an extended, protein-bound state. 
Importantly, bound POT1 coexists in some cases with G4 DNA on the same Tel16 molecule. 
Together our data indicate that POT1 binding to unfolded segments of telomeric tails may 
destabilize existing G4 structures on that tail, thereby enabling the telomere t-loop/D-loop 
conformation or extension by telomerase. 
 47 
a 13-repeat telomeric oligonucleotides in which only two quadruplexes formed on average(79).  
However, the normalized G4 distributions of Tel16 images demonstrated a sharp peak at two 
quadruplexes, whereas the probabilistic model based on the first-principles combinatoric 
approach predicted a nearly equal quantity of molecules with three quadruplexes as well (Fig. 
2.4B). The discrepancy between our experimental observations and the probabilistic models may 
be explained by differences in the probability of forming G4 at different positions along the 
length of Tel16. A previous study using DMS footprinting and exonuclease hydrolysis with 
T24(TTAGGG)7 DNA substrates revealed that the probability of forming G4 rapidly decreases 
towards the 5’ flanking sequence(98), from 55.8% at the 3’ end (0 position) to 21.8%, 14.5% and 
7.9% at the first, and second and third positions (next to 5’ flanking sequence), respectively. Our 
model (Fig. 2.4B) presumes that probabilities of forming G4 along the 3’ G-rich tail of Tel16 are 
the same. The dramatic decrease in the probability of forming G4 units when the repeat positions 
are close to the 5’ flanking region, effectively shortens the number of available repeats for G4 
folding on Tel16. This explanation is supported by the close agreement of the normalized G4 
distributions from the experimental data with the theoretical G4 distributions of two shorter 
substrates with 13 and 14 repeats, repeats (Fig. 2.4B), the former of which was experimentally 
verified to preferentially form two quadruplexes(79). A previous report indicated that while 
GGG(TTAGGG)3
 
 is the most stable, as repeat number increases (n=7-16) the quadruplex 
molecules become less thermostable(77). The presence of loops with various length on the 
tetraplex sides can potentially lead to irregularities in G4 structure and, consequently, to the 
structure destabilization. Current literature suggests that loop length and composition strongly  
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Figure 2.11  
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Fig. 2.11 Telomeric constructs, PCR fragments, and AFM volume analysis.  (A) to (C) are 
representative field view images of Tel4, Tel8 and Tel16, respectively. The images are 1 μm × 1 
μm. The color bar in A represents heights from 0-2 nm. The scale bars are 250 nm. (D) A 
representative AFM surface plot of 517 bp long PCR fragments. (E) The histogram of volume 
measured from AFM images of Tel4 (open bars), Tel8 (gray bars) and Tel16 (black bars). The 
dotted lines represent Gaussian fits to the data. The mean AFM volumes of Tel4, Tel8 and Tel16 
are: 40 (± 2), 57 (± 4) and 106 (± 3) nm3
 
 (3 depositions for each substrate), respectively. It is 
worth noting that the mean volume of Tel16 is slightly larger than simple addition of two single 
G4 measured from Tel4 images. This is partly due to the inclusion of unfolded structures 
alongside with G4 on individual Tel16 molecules since AFM derived volume is a measurement 
of total volume above the noise level (see Methods). 
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influence the quadruplex stability, and quadruplexes formed by (TTAGGG)5 
The arrangement of G4 DNA on longer physiological telomeric tails has been 
controversial. One melting study supported a beads-on-a-string conformation whereby long 
telomeric substrates fold into the maximum potential number of quadruplexes and the 
quadruplexes do not directly interact with each other(78). Another study found that a stacked 
model whereby individual quadruplexes fold in a way that their loop reactions interact, and a 
more rigid superstructure is formed(105;119).  Direct visualization of individual molecules in 
our study revealed that 23% and 1% of the measured Tel16 molecules had two and three 
discernable peaks, respectively. These results support a beads-on-a-string model whereby the 
quadruplexes form as individual G4 units separated by stretches of ssDNA, creating a more 
flexible structure with discernable peaks (Figs. 2.2, 2.3, 2.12).  While not all the molecules 
displayed distinct peaks, this was likely due to the resolution limits of the AFM under the current 
imaging conditions.  If two quadruplexes are linked by a TTA linker, the AFM cannot resolve 
two individual peaks; roughly 1.5 telomeric repeats are required to resolve two peaks (for the 
calculation of AFM resolution see Chapter 4.1 ).  Also, while the average height of the Tel16 
molecules was 1.32 (± 0.22) nm, the average height of the G-wires was 1.63 (± 0.17) nm, 
suggesting that Tel16 G4 DNA is more flexible, corroborating a beads-on-a-string arrangement.   
Previous studies indicated that POT1 binding to substrates with four repeats trapped the 
molecules in an extended state, shifting the equilibrium from a folded G4 unit to an extended 
conformation(103;124). However, the arrangement of G4 DNA and the competition with POT1 
binding on a long, physiologically realistic telomeric substrates was unknown.  Our finding that 
the majority of Tel16 molecules only form two G4 structures has important implications for 
with a 9-nt-loop 
loops were less stable than the one made of 4 consecutive repeats(98). 
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POT1 loading on physiologically relevant telomeric tails. POT1 can not bind the short 
(TTAGGG)4 
We propose that POT1 binds to the unfolded ssDNA regions, and sterically impairs 
adjacent telomeric repeats from folding into G4 DNA, thereby promoting unfolding into 
extended ssDNA (Fig. 2.13B). This is in contrast to the previous passive model, in which 
telomeric tails can be maximally folded in G4 DNA and POT1 is incapable of binding until the 
equilibrium shifts from G4 to ssDNA (Fig. 2.13 A). The steric driver model is consistent with 
results from AFM imaging of Ctrl16 and Tel16 with POT1 (Fig. 2.10). Specifically, upon 
addition of POT1, the equilibrium shifts from a majority of Tel16 molecules forming two 
quadruplexes to one quadruplex and/or multiple POT1 monomers bound (Fig. 2.10). 
Importantly, multiple POT1 molecules bind Tel16 and the non-G4 forming Ctrl16 substrate to 
similar extents, leading to protein arrays of roughly equal length distributions (Fig. 2.10F). If 
POT1 can only capture the ssDNA when the equilibrium shifts from G4 DNA to ssDNA, then 
we would expect a greater number of molecules with long POT1-bound regions for Ctrl16 
relative to Tel16, since POT1 does not need to compete with G4-folding to bind Ctrl16. 
 substrates until the equilibrium shifts from G4 structure to an extended state(103). 
In contrast, on the physiologically relevant Tel16 substrates, an underfolded Tel16 molecule 
constantly has multiple ssDNA sites available for POT1 binding; therefore, POT1 loading does 
not require thermal melting of existing G4 DNA. 
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Fig. 2.12 Interpeak distance distributions on Tel16. Examples of the measurement of interpeak 
distance are shown in Fig. 3. The mean interpeak distance, 20 nm, corresponds to ~40 
nucleotides (~7 telomeric repeats, assuming 0.5 nm/per base). 
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Fig. 2.13  Comparison of the passive and steric driver models of POT1 binding. A 3’ telomeric 
tail with 16 TTAGGG repeats is drawn as an example. POT1 is shown as gray ovals bound close 
to 3’ end. (A) A passive model whereby G4 DNA is arranged on a beads-on-a-string, maximally-
folded telomeric tail. POT1 could not bind the telomeric sequence until the equilibrium shifts 
from G4 to an extended state.  Then POT1 traps the molecule in the extended state.  (B)  In a 
steric driver model, at equilibrium the telomeric tails rarely form the maximum potential number 
of G4 units. POT1 is able to bind unfolded telomeric repeats and destabilize existing G4 DNA on 
the same molecule. Multiple POT1 molecules can bind to the different stretches of ssDNA on the 
same 3’ telomeric tail and impose an emergent synergistic effect against G4 folding. 
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 In summary, we propose a model whereby POT1 acts not as an active DNA unwinder, 
but rather as a “steric driver” by binding to underfolded telomeric tails and thereby destabilizing 
the remaining G4 structures on the molecule (Fig.2.13B), as evidenced by the reduction of G4 
DNA structures upon POT1 addition (Fig. 2.10E). Our results provide a mechanism whereby a 
passive DNA binding protein may still impose an emergent synergistic effect against G4 DNA 
folding, which is consistent with previous studies on S. pombe POT1 DNA-binding 
studies(125;126). POT1 binding competition with G4 DNA folding on physiologically relevant 
3’ telomeric tails suggests an important mechanism for preserving telomere stability. At the late 
G2
 
 phase, POT1 levels at the telomere ends decrease, and the telomeres are temporarily 
recognized as DNA damage and are unprotected by the telomere complex before POT1 
relocalizes to the telomeres(127). Since the unprotected tail can spontaneously fold into G4 
DNA, this raises the issue of how POT1 reloads on the telomeric tail(128-130). Another study 
demonstrated that a G4-stabilizing agent induced an ATR-dependent DNA damage response, but 
that POT1 levels at the telomere ends remained unchanged(131), implying that G4 DNA and 
POT1 may coexist at telomere ends. The AFM images in this study show that the underfolding 
(i.e. formation of less than the maximum potential number of G4 units) of long telomeric ssDNA 
provides a route for POT1 binding and that POT1 and G4DNA can coexist on the same 3’ 
telomeric tail. The direct visualization of single molecules that resemble physiologically relevant 
telomeric tails provide a mechanistic basis for understanding the modulation of telomere 
structure and function by POT1 and G4 DNA.     
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2.4 MATERIALS AND METHODS 
 
DNA Substrates. All oligonucleotides were purchased from Integrated DNA Technologies and 
were purified using PAGE by the manufacturer. The sequences of the oligos are listed in 
Supplementary Table 1. DNA substrates which contain a 5’ duplex region and a 3’ single-
stranded tail were formed by incubating equal molar amounts of oligonucleotides in 1X 
phosphate buffer (10 mM potassium phosphate and 150 mM KCl) or 1X POT1 buffer (40 mM 
Hepes pH 7.5 and 50 mM KCl) at 85o 
Protein p urification. Recombinant GST tagged and untagged POT1 proteins were purified 
using a baculovirus/insect cell expression system and an AKTA Explorer FPLC (GE Health 
Care, Piscataway, NJ) as described previously(132). Protein concentrations were determined 
using Coomassie staining along with a standard of known concentration. Proteins used in this 
study are more than 90% pure based on SDS-PAGE and Coomassie staining. 
C for 5 mins, followed by slow cooling to room 
temperature.  
AFM sample preparation and imaging. All DNA substrates and POT1 protein were diluted in 
1X POT1 buffer containing additional 10 mM MgCl2 for AFM imaging. All buffers were heated 
at 65 degree for 15 to 30 mins to dissolve small salt particles accumulated during storage. When 
POT1 was present, DNA and proteins were incubated at 37o C for 10 mins. G-wire solution was 
prepared by incubating a 270 μM solution of G4T2G4 monomer in 100 mM potassium phosphate 
buffer (pH 7) at 90 oC for 10 minutes and slow cooling to room temperature, followed by 
incubation at 4 oC for 12 hrs. All samples for AFM imaging were prepared by depositing samples 
onto a freshly cleaved mica (SPI Supply, West Chester, PA), followed by washing with MilliQ 
water and drying under a stream of nitrogen gas. All images were collected using a MultiMode V 
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microscope (Veeco Instruments, Plainview, NY) using Escanners in tapping mode. Pointprobe®
The combinatoric model for G4 formation. Statistical analysis of G4 formation on Tel8, 
Tel13, Tel14, Tel15 and Tel16 were calculated by treating them as a sequence of 8 and 13-16 
lattices, respectively.  It was assumed that G4 structures can form by four consecutive TTAGGG 
repeats and that individual G4s can fold randomly along the entire length of the lattice.  The 
number of possible arrangements of the h items (G4s and unstructured repeats) can be described 
as: 
 
plus noncontact/tapping mode silicon probes (PPP-NCL, Agilent) with spring constants of ~50 
N/m and resonance frequencies of ~190 kHz were used. Images were captured at a scan size of 1 
μm × 1 μm, a scan rate of 2-3 Hz, a target amplitude of 0.3 V and a resolution of 512 × 512 
pixels.  
)!(!
!
ihi
hCi
h
−
= where i is the number of G quadruplexes. 
 E.g., for Tel8, there are 5
)!15(!1
!5
1
5 =
−
=C  ways to arrange a single quadruplex, and only 
one way to arrange two quadruplexes.  
Statistical analysis of AFM images. Evaluation of the AFM height at different target 
amplitudes indicated that within the range of target amplitudes used in this study (300 to 400 
mV), the height variation in AFM images of an antibody which is similar in scale to the protein 
and DNA molecules in this study, is ~15% of the total height (Supplementary Fig. S3A). The 
length measurement was done using the Nanoscope7.30 software; structures over 1 nm were 
noted as G4 DNA, whereas POT1 peaks fell between 0.5 and 1 nm. Two discernable G4 peaks 
on Tel16 were defined as presence of two local maxima over 1 nm with a trough in between 
which was at least 0.2 nm lower than the shorter peak (Fig. 3B).  For AFM volume analysis, 
dimension of proteins were measured using Image SXM software(110;116;122). AFM volume of 
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a particle was calculated as V= S × (H - B), where V is the AFM volume, S is the area generated 
at the base of a protein using “density slice” function of the SXM software, H is the average 
height, and B is the background height.   
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Name Sequence (5’ to 3’) 
Tel4-top A GGT ATC AGC ATA ATG GCC ACG GTG CGT ACT GCG (TTAG3)
Tel8-top 
4 
A GGT ATC AGC ATA ATG GCC ACG GTG CGT ACT GCG (TTAG3)
Tel16-top 
8 
A GGT ATC AGC ATA ATG GCC ACG GTG CGT ACT GCG (TTAG3)
Ctrl16-
top 
16 
A G GT A TC A GC ATA AT G GCC AC G GTG C GT ACT  GCG 
(TTAG3TTAGTG)8
Bottom 
  
CGC AGT ACG CAC CGT GGC CAT TAT GCT GAT ACC T  
 
G-wire G4TTG
Note: Complementary regions are shown in bold.  
4 
Duplex DNA substrates are annealed using the following pairs of oligos: 
Tel4=Tel4-top/Bottom; Tel8=Tel8-top/Bottom; Tel16=Tel16-top/Bottom;  
Ctrl16=Ctrl-top/Bottom. 
 
Table 2.1 Oligonucleotides used in Chapter 2. 
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Fig. 2.14 The AFM volume of a globular protein varies linearly with its molecular weight. The 
volumes were determined as described previously(122). The plot corresponds to data for the 
following proteins and their various oligomeric states: PcrA monomer (86.4 kDa), UvrA 
monomer (105 kDa), Taq MutS dimer (181 kDa), UvrA dimer (210 kDa), and Taq MutS 
tetramer (362 kDa). The error bars represent the standard deviation from 2-3 depositions for each 
protein. The blue line corresponds to the least-square fit of the data not including POT1, which is 
described by the following equation: V (nm3) = 0.3735 MW (kDa) + 1.435 (R2=0.9945). Based 
on this equation, the predicted AFM volume of POT1 (72 KDa) is 28 nm3. The red line 
corresponds to the fit of the data including POT1 (R2
 
=0.9883). 
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3.0 TELOMERIC PROTEIN TRF2 PROTECTS HOLLIDAY JUNCTIONS WITH 
TELOMERIC ARMS FROM DISPLACEMENT BY THE WERNER SYNDROME 
HELICASE 
 
The following chapter has been published by Nucleic Acids Research (2010, doi: 
10.1093/nar/gkq144) with authors Gerald J. Nora, Noah A. Buncher, and Patricia L. Opresko.  
 
 
 
 
.
 61 
 3.1 INTRODUCTION 
Lack of the Werner protein (WRN) causes Werner Syndrome (WS), a segmental progeroid 
disorder characterized by cellular genomic and telomeric instability and premature senescence 
(7;11).  WRN is a RecQ family helicase that is unique among the five human RecQ helicases for 
also having an exonuclease domain (20).  Many of the RecQ helicases in general are thought to 
function during DNA replication to prevent replication fork demise and to restore stalled or 
broken replication forks, partly through homologous recombination (HR) pathways (133).  
Consistent with this, WRN protein is implicated in pathways for recombinational repair of stalled 
replication forks and DNA double strand breaks (44;134).  WRN is proposed to have particularly 
important roles in telomere preservation during replication.  Telomeres protect chromosomes 
ends, and telomere dysfunction triggers cellular senescence, apoptosis, or genomic instability (1).  
The forced expression of telomerase in WS fibroblasts suppresses many of the primary cellular 
defects including telomere loss on sister chromatids (18), premature senescence (17), and the 
accumulation of chromosomal aberrations (135).  Cellular and biochemical data indicate that 
WRN may preserve telomeres by dissociating alternate DNA structures to facilitate replication 
fork progression or for completion of HR repair at stalled or broken replication forks (reviewed 
in (7)).  These DNA structures include G-quadruplexes, 4-way junctions that mimic regressed 
replication forks and Holliday Junction (HJ) intermediates in HR, and D-loop structures that 
occur during HR and at the telomeric end (30;34).  All of these are preferred substrates for WRN 
helicase which can also branch migrate HJ and D-loops (34;136).  These studies suggest that 
inappropriate processing of alternate structures at telomeres can lead to premature telomere loss 
and cell senescence or apoptosis.   
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Human telomeres are characterized by repetitions of a short sequence of duplex DNA 
(TTAGGG) and a 3’ overhang of single stranded DNA (ssDNA), bound by the shelterin complex 
of six proteins (1;137).  The 3’ overhang, which may be 50-500 nt, is bent around into a t-loop 
and then invades the duplex DNA, displacing the G-rich strand and forming a displacement loop 
(D-loop) (38).  Telomere D-loop formation is thought to be mechanistically similar to D-loop 
formation during the initiation of homologous recombination (1;36;37).  The shelterin protein 
TRF2 is critically important for stimulating formation and preservation of the telomeric t-loop/D-
loop  structure (57;138;139).  TRF2 has two DNA binding domains: an N-terminal basic domain 
that binds four way junctions regardless of sequence (56) and a C-terminal Myb domain that 
specifically binds duplex TTAGGG repeats (55).  Cellular studies showed that the 
overexpression of TRF2 lacking the B-domain (TRF2ΔB) results in cleavage of the t-loop/D-
loop by HJ resolvase XRCC3 (37), which leads to extra-chromosomal telomeric circles that can 
be visualized by 2-D electrophoresis and electron microscopy (37;140).  TRF2 binds to and 
inhibits cleavage of 4-way junction models of HJ structures in vitro (56;84).  WRN is required 
for the production of telomeric circles in TRF2ΔB overexpressed cells (83), but the mechanism 
is unknown.  Interestingly, in telomerase positive WS cells, telomeric circles form in the absence 
of WRN and independently of XRCC3, implicating WRN in more than one pathway for 
telomere stability (83).  While TRF2 is known to protect HJs from cleavage by HJ resolvases 
(84), whether TRF2 also regulates displacement and migration at the telomere t-loop/D-loop is 
not known.   
One model for WRN promotion of telomeric circles in TRF2∆B expressing cells is that 
WRN stimulates branch migration of the t-loop/D-loop into a target for cleavage. HJ-like 
structures also form preferentially at telomeres during replication fork regression that produces a 
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four-way junction in which one duplex end is accessible (chicken foot) (80).  WRN exonuclease 
can attack this vulnerable end, and  the helicase can displace the 4-way junction (141).  Both 
TRF2 and WRN bind the HJ core in vitro (56;142).  Therefore, it is possible that TRF2 may 
protect HJs from WRN activity by inhibiting WRN loading. Paradoxically, TRF2 binds directly 
to WRN protein in vivo (28;83;143), and in vitro studies showed that TRF2 recruits WRN to 
telomeric substrates (143), stimulates WRN exonuclease digestion of telomeric duplexes (143), 
and stimulates WRN helicase unwinding of short forks (28).  Whether TRF2 modulates WRN 
processing of HJ DNA is not known.     
Given that TRF2 represses WRN promotion of t-circles (83), in this study, we tested the 
hypothesis that TRF2 negatively regulates WRN activity on 4-way structures that may occur at 
the t-loop/D-loop or during replication fork regression.  By testing a variety of HJ substrates 
containing site specific blocks to WRN helicase 3’ to 5’ translocation, we provide evidence that 
WRN displaces 4-way structures from the center moving outward.  We also found that TRF2 
protects telomeric HJ DNA against WRN strand displacement activity.  However, both the TRF2 
B and Myb DNA-binding domains are required for WRN inhibition, indicating that TRF2 must 
engage both the HJ core and the duplex arms to regulate WRN strand displacement.  
 
3.2 MATERIALS AND METHODS 
3.2.1 Proteins 
Recombinant human hexahistidine-tagged WRN protein and the exonuclease-dead E84A WRN 
mutant (X-WRN) were purified from a baculovirus/insect cell expression system as described 
previously (144).  Recombinant human hexahistidine-tagged RPA was provided as a gift from 
Dr. Walter Chazin (Vanderbilt University, TN, USA). Recombinant human hexahistine-tagged 
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TRF2 protein was purified as formerly described (28).  Recombinant hexahistine TRF2 protein 
fragment (amino acids 45 to 501; TRF2∆B) was generated by PCR cloning using the TRF2 
cDNA from the baculovirus DNA construct, kindly provided by Dr. Titia de Lange (Rockefeller 
University, New York, NY) as a template.  The PCR product was subcloned into the BamHI and 
EcoRI sites of the pRSET-A expression vector (Invitrogen, Carlsbad, CA).  The TRF2∆B 
fragment was expressed in BL21(DE3) E. coli and purified with an AKTA Explorer FPLC (GE 
Life Sciences, Piscataway, NJ).  After the induction of TRF2∆B expression with 1 mM IPTG for 
4 hours at 30º C, cells were harvested and resuspended in lysis buffer (20 mM NaH2PO4, 0.5 M 
NaCl, 10 mM imidazole, 1% NP-40 and 5 mM beta-mercaptoethanol) and mixed on a rotator at 
4ºC for 30 min.  Protease inhibitors were included in all buffers (Roche Molecular Biochemicals, 
Indianapolis, IN).  Cells were centrifuged at 15,000 rpm for 30 min at 4oC.  The supernatant was 
loaded onto a HisTrap FF (GE Life Sciences) column equilibrated with lysis buffer.  The column 
was washed with Buffer A (20 mM NaH2PO4, 0.5 M NaCl) containing 10 mM imidazole, and 
subsequently washed and protein eluted with 60 mM and 100 mM imidazole, respectively.  The 
eluant was dialyzed against buffer D (20 mM Hepes, pH 7.9, 100 mM KCl, 3 mM MgCl2, 1 mM 
DTT, 20% glycerol, 0.5 mM PMSF) in Slide-a-lyzer cassettes (Thermo Fisher, Rockford, IL, 
USA) at 4o C.  Protein purity and concentration were determined by SDS PAGE Coomassie 
analysis and Bradford assay, respectively.  The pGEX4T-RAP1 construct was kindly provided 
by Dr. Zhou Songyang (Baylor College of Medicine, Houston, TX).  GST-tagged human RAP1 
was expressed in BL21 (DE3) E. coli and purified on glutathione Sepharose beads (GE Life 
Sciences) in batch followed by thrombin (GE Healthcare) cleavage as previously described with 
some modification (58).  Following the induction of RAP1 expression with 1 mM IPTG for 2 
hours at 37 ºC, cells were harvested at 3,800 rpm for 15 min at 4 ºC, resuspended in lysis buffer 
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(1X PBS, protease inhibitors, 50 mM beta mercaptoethanol, and 1% Triton X-100), sonicated, 
and mixed in a rotator for 15 min at 4ºC.  Cell lysate was harvested at 10,000 rpm for 10 min, 
and the supernatant was incubated with glutathione-sepharose beads (GE Healthcare, 
Piscataway, NJ) for 3 hours at 4ºC on a rotator.  Bound GST-tagged RAP1 was cleaved with 
Thrombin (GE Healthcare) for 12 hours at 4ºC.  The supernatant was loaded onto a Mono Q 5/50 
GL (GE Life Sciences) column equilibrated with Buffer A (150 mM Tris, pH 8.0, 50 mM NaCl, 
0.05% NP-40, and 10% glycerol).  RAP1 protein was eluted in Buffer B (150 mM Tris pH 
8.0,10% glycerol, and 0.05% NP-40) at 335 mM NaCl. Protein purity and concentration were 
determined by SDS PAGE Coomassie analysis and Bradford assay, respectively.  
3.2.2 DNA Substrates 
All oligonucleotides were purchased from Integrated DNA Technologies (Coralville, IA) and 
PAGE-purified by the manufacturer, except for HJbio-4, which was purchased from and PAGE-
purified by Gene Link (Hawthorn, NY, USA).  Fluorescent labels were covalently linked to the 
5’ nucleotide by the manufacturer. Sequences are provided in Supplemental Table 1.  
All HJ constructs, modified from the XJ12 described previously (30) and with the 
exception of HJT (Table 1), were annealed in 25 µL reaction volumes.  For HJ DNA constructs, 
10 or 12 pmol of the indicated oligonucleotide 1 was mixed with a 1:2:3:2 molar ratio with the 
respective 2, 3, and 4 oligonucleotides (Table 1), respectively, in 0.35X PBS and 350 mM LiCl.  
The oligonucleotides were annealed in a TC-312 PCR machine (Techne, Burlington NJ) by 
incubating at 95º C for 5 min, followed by cooling to 65º C at 1 deg./min.  The reactions were 
held at 65º C for 5 min, cooled to 37º C at 1 deg./min, then incubated at 37º C for 8 h and then 
cooled to 10º C. 
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The HJT construct was prepared by first annealing the forked halves of the substrate 
separately in 12.5 µL reactions with 100 mM LiCl and 0.5X TE buffer: one with 10 pmol T-1 
and 20 pmol T-2, and the other with 40 pmol T-3 and 20 pmol T-4.  The reactions were 
incubated at 65º C for 5 min and allowed to cool to 37º C.  To form HJT the separate forked 
duplex reactions were combined, incubated at 37º C for 1 h, and cooled to room temperature.  
A portion of each HJ preparation (0.5 µL) was removed for use as a standard to 
determine the concentration of the purified HJ preparations.  The remainder was mixed with 16 
µL H2O and 7.5 µL 80% glycerol and loaded on an 8% polyacrylamide gel.  Voltage (150 V) 
was applied for 1.5 hours at 4º C.  The HJ products were visualized by fluorescence on a 
Typhoon Imager (GE Healthcare), excised from the gel and purified from the gel slice by 
electroelution for two hours in a Model 422 Electroeluter (Bio-Rad, Hercules CA).  The eluant 
was concentrated in a Microcon YM-30 (Millipore, Billerica MA) and resuspended in 100 µL of 
storage buffer (10 mM Tris pH 7.5, 10 mM MgCl2) and stored at -20º C.  Purification quality 
and yields were determined by analysis on 8% native polyacrylamide gels, followed by 
visualization and quantitation with a Typhoon Imager and ImageQuant software (GE Healthcare, 
Piscataway, NJ). Forked duplexes were prepared by annealing oligonucleotides as described in 
Supplemental Table 1 in 1:1 molar ratios.  Annealing reactions (50 μL) were incubated in 50 mM 
LiCl2
 
 and 0.71X PBS at 95° C for five min and then allowed to cool to room temperature. 
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Fig. 3.1. SDS precipitation and streptavidin addition do not significantly alter WRN activity. 
Schematic of the HJA construct.  T = TAMRA, C = Cy5, and A = Alexa488 labeled 
oligonucleotides.  The 3’ end of the exonuclease vulnerable T-oligo is highlight as a dotted line.  
(A) The HJA substrate (0.5 nM) was incubated under standard reaction conditions with 15 nM 
X-WRN (exonuclease-dead WRN) for 1 h.  Streptavidin (30 nM) was included in the reactions 
for lanes 8 and 9.  The reactions were terminated with 2.7x control buffer (lanes 2-3; identical to 
ProtK-SDS buffer only without LiCl; see Materials an d Met hods) or ProtK-SDS buffer and 
precipitated as described in Materials an d Met hods (lanes 5-9).  ▲, boiled substrate.  The 
reactions were separated on an 8% native gel and imaged in the Cy5 emission channel.  (B) 
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Quantitation of the displaced HJ DNA.  The percent of displaced HJ DNA was quantitated as 
described in Materials and Methods.  Values represent the mean and standard deviation from 
two or three independent experiments. 
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3.2.3 Helicase/Exonuclease Reactions 
HJ substrates were reacted in standard reaction buffer (40 mM Tris pH 7.5, 4 mM MgCl2, 5 mM 
dithiothreitol (DTT), 0.1 mg/mL bovine serum albumin (BSA) and 2 mM ATP) at 37o
The TAMRA, Cy5, and Alexa488 fluorophores were visualized on a Typhoon Imager 
using the preset TAMRA, Cy5, and Alexa488 laser excitation and emission settings, with a 
photomultiplier gain of 575 V for all channels and normal sensitivity.  Control reactions ensured 
that cross talk between channels did not occur (Fig. 3.4).  Reaction substrates and products were 
quantified using ImageQuant 5.1 (GE Life Sciences) software.  The local median analysis was 
used for background correction.  Substrate and products were calculated as the percent of the 
C for 
various time points as indicated in the Figure legends.  The concentrations of substrate and 
proteins WRN, X-WRN, TRF2, TRF2∆B and RPA were as indicated in the Figure legends.  
Reactions were started by WRN or X-WRN addition, and terminated by adding 2.7X stop dye 
(50 mM EDTA , 40% glycerol).  The reactions that included RPA and/or TRF2 were terminated 
with 2.7X ProtK-SDS stop dye (15 mM EDTA, 1 µg/mL proteinase K, 300 mM LiCl, 1.5% 
SDS) and incubated at 37º C for 30 min.  Because SDS fluoresces and interferes with analysis of 
the fluorescent substrates, it was precipitated based on a protocol by Zhitkovich and Costa (145).  
Briefly, 4 µL 1 M KCl was added to the 31.5 µl stopped reactions, followed by incubation on ice 
for 5 min.  The precipitate was pelleted by centrifugation for 10 min at 10,000 x g at 4º C.  The 
supernatant (31 µL) was drawn off and transferred to a fresh tube with 15 µL of loading buffer 
(40% glycerol, 0.5X TE). The SDS precipitation procedure did not result in any significant 
reannealing of the dissociated ssDNA products (Fig. 3.1).  The terminated reactions were run on 
either 8 or 12% native polyacrylamide gels as indicated in the Fig. legends at 150 V.  
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total DNA in each lane for each fluorophore.  All values were corrected for background in the no 
protein and boiled control lanes as described previously (33). 
3.2.4 Electrophoretic mobility shift assay 
Binding reactions (10 µl) contained standard reaction buffer (40 mM Tris pH 7.5, 4 mM MgCl2
 
, 
5 mM DTT, 0.1 mg/mL BSA, 2 mM ATP), 5% glycerol, and 5 nM DNA substrate.   The 
reactions were initiated by adding various concentrations of TRF2, as indicated in the Fig. 
legend, and were incubated for 20 min at room temperature.  The reactions were loaded on 1% 
agarose gels and electrophoresed in 0.5X TBE at 4º C and 140 V for one hour.  The fluorescent 
products and substrates were visualized and analyzed as described for the helicase reactions. 
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Table 3.1  Holliday Junction Substrates. T = TAMRA; C = Cy5; A = Alexa488. Dotted lines 
denote an oligonucleotide with an exonuclease-vulnerable 3’ end lacking a thiophosphate bond 
protection. Bold lines indicate the G-rich strand of telomeric repeats.  Trapezoid denotes biotin; 
open rectangle denotes PEG linker. Numbers denote oligonucleotides used (Table 3.2).  
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Table 3.2 List of oligonucleotides used in Chapter 3. 
1 5'TMR-TACGCTGCCGAATTCTGGCTTGCTAGGACATCTTTGCCCACG TTGACCCA 
2 5'TGGGTCAACGTGGGCAAAGATGTCCTAGCAATGTAATCGTCTATGACGT*C 
3 5'Cy5GACGTCATAGACGATTACATTGCTAGGACATGCTGTCTAGAGACTATCG*A 
4 5'TCGATAGTCTCTAGACAGGATGTCCTAGCAAGCCAGAATTCGGCAGCGT*A 
 Biotinylated substrates 
bio-1 5'TMR-TACGCTGCCGAATTCTGGCTTGCTbio AGGACATCTTTGCCCACG TTGACCCA 
3b 5'GACGTCATAGACGATTACATTGCTAGGACATGCAGTCTAGAGACTATCG*A 
3bio 5'GACGTCATAGACGATTACATTGCTAGGACATGCAGTCTAGAGACTATCG*A-bio 
4bio 5'AlexaTCGATAGTCTCTAGACTbioGCATGTCCTAGCAAGCCAGAATTCGGCAGCGT*A 
 PEGylated substrates 
PEG-3’ 5'TMR-TACGCTGCCGAATTCTGGCTTGCTAGGACATCTTT-PEG-CACG TTGACCCA 
PEG-5’ 5'TMR-TACGCTGCCGAA-PEG-TGGCTTGCTAGGACATCTTTGCCCACG TTGACCCA 
 Telomeric-repeat-containing (“hybrid”) substrates 
C-1 5'TMR-TACGCTGCCGAATTCTGGCTTGCTAGGACATTTAGGGTTAGGGTTA GGG 
C-2 5'Cy5-CCCTAACCCTAACCCTAAATG TCCTAGCAACCCTAACCCTAACCCTA*A-3 
C-3 5'Alexa-TTAGGGTTAGGGTTAGGGTTGCTAGGACATGCTGTCTAGAGACTATCG*A 
C-4 5'TCGATAGTCTCTAGACAGCATGTCCTAGCAAGCCAGAATTCGGCAGCGT*A 
T-1 5'TMR-TACGCTGCCGAATTCTGGCTTGCTGGACATTTAGGGTTAGGGTTAGG*G 
T-2 5'Cy5-CCCTAACCCTAACCCTAAATGTCCTAGCAATGTAATCGTCTATGACGT*C 
T-3 5'GACGTCATAGACGATTACATTGCTAGGACATCCCTA ACC CTA ACC CTA*A-3' 
T-4 5'Alex-TTAGGGTTAGGGTTAGGGATGTCCAGCAAGCCAGAATTCGG AGCGT*A 
M-1 5'Cy5-AATCATCGTCCTAGCAAGGTTAGGGTTAGGGGGCTGCTACCGGCACTGCG 
M-2 5’CGCAGTGCCGGTAGCAGCCCCCTAACCCTAATGAGCGGTGGTTATCCA*G 
M-3 5'CCTGGATAACCACCGCTCATTAGGGTTAGGGACTCAACTGCAGTCGCTT*G 
M-4 5'CAAGCGACTGCAGTTGAGTCCCTAACCCTAACCTTGCTAGGACGATGAT*T 
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3.3 RESULTS 
3.3.1 WRN helicase and exonuclease activities simultaneously process Holliday Junctions 
Prior to investigating TRF2 modulation of WRN activity on HJ substrates, we required a more 
complete understanding of WRN mechanism for HJ dissociation.  Previous independent studies 
demonstrated WRN exonuclease activity at the 3’ blunt end of a static 4-way junction (141) and 
WRN helicase dissociation of a 4-way junction with a mobile homologous core (30).  Therefore, 
we asked whether both activities can simultaneously process a model HJ with a mobile core.  To 
test this, we developed a multiplex fluorophore imaging method to track the fate of individual 
strands of a 4-way construct in with three strands were labeled with a unique fluorophore.  
Previous studies with 4-way junctions monitored substrate conversion to ssDNA by tracking 
migration of one radio-labeled strand in the construct.  While current fluorophores still suffer the 
disadvantage of decreased sensitivity compared to 32
Each arm of the HJA construct (Table 3.1 ) is 25 bp long with a 12-nucleotide 
homologous center (30).  Since a 4-way junction is unlikely to have four exposed ends in vivo, 
all the 3' ends except for the T-oligonucleotide contained a thiophosphate bond to protect against 
exonuclease activity.  One exposed end mimics a regressed replication fork which is thought to 
be a target for WRN (134;142;146). WRN processing of the HJA substrate led to a variety of 
displaced DNA products that were uniquely identified by their fluorescent tags (potential 
products shown separately in Fig. 3.3).  The appearance of a forked duplex preceded the 
P radioactivity, they offer the distinct 
advantage of identifying the exact oligonucleotide composition of all intermediates and products 
present in each band on a gel.  This is particularly critical if the HJ construct is asymmetric due 
to the presence of telomeric repeats or chemically modified bases in some arms, as in many of 
the HJs in this study (Table 3.1). 
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appearance of ssDNA product (Fig. 3.2A), as shown schematically in Fig. 3.2B.  The distribution 
of the T-oligo, which contains the unprotected 3’end, among the various intermediates and 
products was quantitated (Fig. 3.2C).  In the first eight minutes of the reaction less than 5% of 
the HJ was unwound and the predominant displaced T-oligo species was an intact fork duplex 
(3% of the total DNA) (Fig. 3.2A, lanes 2-10 and 3.2C).  After 16 minutes, both T-oligo 
exonuclease degraded fork (exo-fork) and ssDNA (exo-ssDNA) species began to predominate 
(8% and 3%, respectively), and increased linearly with time to 19% and 18%, respectively, at 60 
minutes (Fig. 3.2C).  After 60 minutes the amount of intact T-oligo in a fork or as ssDNA was 
low (< 3%) or negligible, respectively, indicating robust WRN exonuclease attack of the 
vulnerable arm during the reaction (Fig. 3.2D).  Upon completion the A-oligo, which pairs with 
both the T- and C-oligos in the HJ, was evenly divided between an intact fork with the C-oligo 
(8%) and a degraded fork with the T-oligo (11%; Fig. 3.2D).  Similar amounts of fork and 
ssDNA product were detected for each oligo, indicating no apparent bias for dissociation of any 
of the arms (Fig. 3.2D).  Our data are consistent with a mechanism for HJ processing in which 
WRN simultaneously displaces the HJ into forks while degrading the vulnerable T-oligo, 
followed by fork displacement to ssDNA. 
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Fig. 3.2. WRN helicase and exonuclease simultaneously process HJ DNA. (A)  HJA (2 nM) was 
incubated with 24 nM WRN in standard reaction buffer at 37oC.  Aliquots were terminated at 
various times from 0.5 to 60 min in two-fold increments (lanes 2-10).  Reactions were run on a 
12% native polyacrylamide gel and were visualized with a Typhoon Imager in the TAMRA 
(blue), Cy5 (green), and Alexa 488 (red) channels.  Colors assigned by Imagequant software.  
The exonuclease degraded products are indicated as (a) = exo-fork and (b) = exo-ssDNA.  (B)  
Schematic of WRN strand displacement and exonuclease products. T = TAMRA, C = Cy5, and 
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A = Alexa488 labeled oligonucleotides.  The 3’ end of the exonuclease vulnerable T-oligo is 
highlight as a dotted line.  (C)  The percent of displaced T-oligo products from the reactions in 
(A) were quantitated as describe in Materials an d Met hods and plotted against time.  Intact 
fork, solid black line and squares; exonuclease-degraded fork, dashed black line and triangles; 
intact ssDNA, solid gray line and squares; exonuclease-degraded ssDNA, dashed gray line and 
triangles.   (D)  Substrate and product distribution for each labeled oligonucleotide in the HJ 
construct after 1 h reaction.  The percent of T-, A- and C-oligos present in the HJ substrate and 
each intermediate and product were quantitated as a function of total oligonucleotide as 
described in Materials and Methods.  Values represent the means and standard deviations of 
two or three separate experiments.  
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Fig. 3.3 Potential products from WRN helicase displacement of the HJA construct. Schematic of 
the HJA construct.  T = TAMRA, C = Cy5, and A = Alexa488 labeled oligonucleotides.  The 3’ 
end of the exonuclease vulnerable T-oligo is highlight as a dotted line.   Products were run on a 
12% native polyacrylamide gel and were visualized with a Typhoon Imager in the TAMRA 
(blue), Cy5 (green), and Alexa 488 (red) channels.  Colors assigned by Imagequant software. (A) 
T-oligo (lane 1), C-oligo (lane 2), A-oligo (lane 3).  (B) HJA substrate (lane 1), T- and A- oligos 
in a forked duplex (lane 2), T- and unlabeled oligos in a forked duplex (lane 3), C- and unlabeled 
oligos in a forked duplex (lane 4) and C- and A- oligos in a forked duplex (lane 5).    
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Fig. 3.4 Fluorophore emission demonstrates negligible crosstalk. A, TAMRA emission channel; 
B, Cy5 emission channel; C, Alexa488 emisison channel. HJA substrate (lane 1), T- and A- 
oligos in a forked duplex (lane 2), T- and unlabeled oligos in a forked duplex (lane 3), C- and 
unlabeled oligos in a forked duplex (lane 4) and C- and A- oligos in a forked duplex (lane 5).   
 
 79 
3.3.2 WRN helicase initiates HJ strand displacement at the center  
WRN binds the HJ core and is presumed to initiate unwinding from the center (142).  However, 
while WRN helicase is inactive on blunt ended dsDNA, the WRN exonuclease can digest the 
blunt ends of substrates that contain junctions such as forks, bubbles or HJs, presumably by 
WRN first loading at the junction site (142).  Therefore, it is formally possible that WRN 
helicase may also initiate strand displacement from the blunt end of an HJ, such as at a regressed 
replication fork, which may bypass effects of TRF2 bound at the core.  To test the mechanism of 
HJ unwinding we used strategically placed biotin/streptavidin blocks. We and others showed that 
while a biotin does not interfere with WRN helicase activity (Fig. 3.1), a biotin/streptavidin 
complex can inhibit strand displacement (34).  Control experiments confirmed that a 
biotin/streptavidin complex inhibits X-WRN unwinding of a forked duplex only when present on 
the translocating strand (Fig. 3.5A), but not when present on the non-translocating strand (Fig. 
3.5B).  Slower migration of the fork and ssDNA product upon streptavidin addition confirms the 
presence of a biotin/streptavidin complex.  An exonuclease-dead variant of WRN (X-WRN) was 
used to examine helicase alone.  Since WRN helicase is poorly processive, RPA was required to 
increase product yield for detection of potential inhibition, but did not relieve the 
biotin/streptavidin block to WRN unwinding and does not melt the duplex (Fig. 3.10).  
We reasoned that if WRN initiates unwinding from the HJ center then a 
biotin/streptavidin block at the core, 24 nucleotides from the 5’end of the T-oligo (HJbio-center), 
would inhibit WRN 3’ to 5’ translocation on the T-oligo through the T/A duplex arm (Fig. 3.6A 
III, open arrows).  However, unwinding in the "vertical" axis (dark arrows) would be permitted 
(Fig. 3.6A, dark arrows) yielding products that included the T-oligo trapped in a fork with the A-
oligo.  When HJbio-center was incubated with X-WRN and RPA, 47% and 89% of the T- and A-
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oligos were liberated as ssDNA, respectively (Figs 3.6B, C lane 2, and 3.6D). Some of the T-
oligo was released as a fork with the unlabelled oligo, but not with the A-oligo, perhaps due to 
greater G/C content on the HJ arm composed of the T-oligo and the unlabeled strand (Table 3.2).  
Upon streptavidin addition, the displaced ssDNA product decreased substantially to 17% and 
55% for the T- and A-oligos, respectively (Figs 3.6B, C  lane 5, and 3.6D).  Importantly, 
streptavidin addition yielded a novel forked species consisting of the T- and A-oligos (total of 
31% and 15%, respectively, since a T/unlabeled fork is also present) and a novel triple stranded 
species consisting of the T- and A-oligos (17% and 15%, respectively) bound to the unlabeled 
oligo.  These species contained negligible amounts of C-oligo (1%; Fig. 3. 7) and the 3-way 
probably resulted from shifting between two conformations (Fig. 3.6E).  The 12 nucleotide 
homologous core can shift the biotin/streptavidin block from the T/A duplex arm (Fig. 3.6A, I 
and II) to the T/unlabeled duplex arm (Fig. 3.6A, III), whereas the C-oligo is never present in a 
duplex arm with a biotin (Fig. 3.7A).  These dynamic conformations likely explain the lack of 
complete WRN inhibition and the generation of a novel 3-way species by a biotin/strepativin 
barrier at the HJ core.     
To test whether WRN can load on the HJ blunt end and translocate toward the center 
while unwinding, we asked if a 3' biotin/streptavidin complex on the A-oligo would inhibit WRN 
helicase activity (HJbio-end) (Fig. 3.6A).  In contrast to HJbio-center, streptavidin addition to 
HJbio-end did not alter strand displacement by X-WRN and RPA.  Approximately 95% of the A-
oligo was displaced as ssDNA in the absence or presence of streptavidin (Fig. 3.6A, lanes 2-4 or 
7, respectively), and the 3-way product observed in the HJbio-center reactions was not apparent.  
Furthermore, RPA alone does not melt the HJ (Fig. 3.16).  These data indicate that a 
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biotin/streptavidin complex at the HJ core, but not at the HJ blunt end, inhibits WRN strand 
displacement.  
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Fig. 3.5 Biotin-streptavidin complex on the translocating strand inhibits WRN activity. Reactions 
contained a 31-bp forked duplex (0.5 nM) with a biotinylated nucleotide (inverted trapezoid) on 
the WRN translocating (A) or nontranslocating strand (B).  Black box denotes streptavidin. The 
forks were constructed by annealing oligonucleotides bio-1 and 4 (A) or bio-1 and 2 (B) 
(Supplemental Table 1). T = TAMRA; A= Alexa488.  The duplex length (bp) on either side of 
the biotinylated nucleotide is shown.  The substrate was pre-incubated with either 0 (lanes 1-2) 
or 30 nM (lanes 3-4) streptavidin in standard reaction buffer prior to adding 3.4 nM X-WRN and 
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12 nM RPA. Reactions were for 20 min at 37o
 
C, and were run on an 8% native polyacrylamide 
gel for 2.5 hrs and visualized with a Typhoon imager.  A streptavidin-bound T-oligo was loaded 
(lane 6) as a marker and the boiled substrate lane is indicated with a triangle (lane 5). The gel 
scans show the TAMRA emission channel. (C)  Quantitation of the ssDNA product.  The percent 
of ssDNA T-oligo product was quantitated as described in Materials a nd Met hods.  Values 
represent the means and s.e.m. from two independent experiments.  
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Figure  3.6 
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Fig. 3.6 A biotin-streptavidin complex at the HJ core impedes WRN helicase activity.  (A) The 
HJbio-center construct has a 12-nucleotide homologous core that permits branch migration.  The 
center construct (II) shows the HJ in a symmetric conformation with 25 bp arms.  The left and 
right constructs (I and III) show the possible extreme conformations.  T = TAMRA; C = Cy5; A 
= Alexa488; inverted trapezoid denotes a biotin moiety. Black box denotes a streptavidin.  The 
predicated possible directions of unwinding are shown for each conformation; white arrow 
denotes unwinding along the horizontal axis; black arrow denotes unwinding along the vertical 
axis.  (B and C)  The HJbio-center substrate (0.5 nM) was pre-incubated without (lanes 1-2) or 
with (lanes 4-5) 30 nM streptavidin under standard reaction conditions prior the addition of 15 
nM X-WRN and 45 nM RPA.  The reactions were conducted for 1 h at 37o
 
C.  The products were 
run on an 8% native acrylamide gel for 2.5 hrs and visualized with a Typhoon Imager.  Black 
triangle denotes boiled substrate lane. The TAMRA and Alexa488 emission channels are shown 
in (B) and (C), respectively.  (D)  Quantitation of ssDNA reaction products.  The percent of T-
oligo (grey bars) and A-oligo (white bars) detected as ssDNA product was quantitated as 
described in Materials and Methods.  The values represent the means and standard deviations 
from two to four independent experiments.  (E)  Schematic of the 3-way product species that are 
generated upon addition of streptavidin.  
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Fig. 3.7 Streptavidin-biotin barrier fails to create a triple-stranded species with C-oligo 
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Fig. 3.8 A biotin-streptavidin complex at the 3' end of an HJ arm does not alter WRN activity. 
The HJbio-end substrate has a biotin tag at the 3' end of the  A-oligo.  T = TAMRA; C = Cy5; A 
= Alexa488; inverted trapezoid denotes a biotin moiety. Black box denotes streptavidin. (A)  The 
HJbio-center (0.5 nM) substrate was pre-incubated without (lanes 2-4) or with (lanes 6-7) 30 nM 
streptavidin under standard reaction conditions prior the addition of 15 nM X-WRN and 45 nM 
RPA.  The reactions were conducted for 1 h at 37oC.  The products were run on an 8% native 
acrylamide gel for 2.5 hrs and visualized with a Typhoon Imager. Black triangle denotes boiled 
lane. M denotes an A-oligo ssDNA marker bound by streptavidin. The Alexa488 emission 
channel is shown. (B) Quantitation of ssDNA reaction products.  The percent A-oligo detected as 
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ssDNA product was quantitated as described in Materials and Methods.  The values represent 
the means and standard deviations from three independent experiments. 
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Prior to the biotin-streptavidin barriers, we had experimented with PEG linkers to 
interrupt the DNA backbone, which would also create a barrier to WRN helicase. We found that 
if the PEG linker interrupted the translocating strand of a forked duplex (Peg-1), the X-WRN 
unwinding was severely inhibited, unwinding only 1% of the forked substrate at a 0.75:1 ratio of 
RPA to X-WRN, and unwinding 9% at a 3:1 RPA:X-WRN ratio (Fig. 3.9A, C). By contrast, if 
the PEG linker interrupted the complement of the strand upon which X-WRN translocated (Peg-
2),  there was six-fold more unwinding at the 3:1 RPA:X-WRN ratio compared to when the PEG 
was in the translocating strand. (Fig. 3.9B,C).  
We then tested the effect of PEG linkers on a Holliday Junction construct in order to 
determine where WRN helicase initiates unwinding of the HJ DNA. We constructed two HJs 
identical to HJA (Table 3.1) but for the replacement of three nucleotides on the TAMRA-labeled 
oligonucleotide with a PEG linker on the 5’ or 3’ half of the oligonucleotide (HJ-5’ and HJ-3’, 
respectively; Table 2.1 ; Fig. 3.10A,B, respectively). If WRN helicase unwinds HJ from the 
center and progresses outward, then we predict WRN would not unwind HJ-5’, but would 
unwind HJ-3’. We observed that HJ-5’ was poorly unwound by X-WRN alone under standard 
conditions, with more than 90% of the HJ remaining (Fig. 3.10C) after one hour. This was half 
the amount of unwinding seen with X-WRN alone with the HJ-3’ construct (Fig. 3.10D), where 
the PEG linker is on the 3’ half. Because at most only 20% of the PEG-containing HJ constructs 
were unwound by X-WRN alone after one hour, we used RPA to produce more unwinding to 
enhance the ability to detect a potential difference in unwinding between the two constructs. 
With the addition of RPA in a 3:1 molar ratio over X-WRN, HJ-5’ unwinding incrased nearly 
10-fold, with 50% more HJ-3’ A-oligo being unwound than HJ-5’(Fig. 3.10C). The relative 
inhibition of X-WRN-mediated unwinding of the HJ with the PEG at the 5’end of the TAMRA 
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strand, compared to the HJ with the PEG at the 3’ end of the TAMRA strand, is consistent with a 
model in which WRN initiates unwinding from the center of the HJ.  
To confirm that WRN helicase does not initiate unwinding from the end of HJ DNA, we 
created a 5' PEG HJ DNA (HJ-5bio) construct as above with a 3' biotin tag on the 3' end of the 
Alexa488-labeled fluorophore (Fig. 3.11 ; Table 3.1 ). Biotin-streptavidin complexes have been 
used to block WRN helicase processivity and thus determine mechanisms of unwinding different 
substrates(147). We hypothesized that if WRN helicase initiated unwinding from the center of 
the Holliday Junction, then WRN unwinding should not be significantly changed by the presence 
or absence of streptavidin. However, if WRN helicase initiated unwinding from the edge of the 
HJ and moved inward, the presence of streptavidin should block WRN activity. When we reacted 
HJ-5bio with 3:1 RPA:X-WRN under standard conditions, we found that the presence or absence 
of streptavidin in a 60:1 ratio with DNA did not significantly alter unwinding (Fig. 3.11A), with 
44% HJ DNA unwound without strepavidin, and 48% being unwound with streptavidin (Fig. 
3.11C). The replacement of basepaired DNA with the linker probably destabilized the HJ, 
especially since branch migration could result in the PEG linker being only 9 basepairs from the 
center. A biotin-streptavidin barrier does not remove basepairs, thus creating a more stable 
construct. 
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Fig. 3.9 A PEG linker on the translocating strand inhibits an X-WRN-RPA complex. Reactions 
contained 1 nM of a forked 31 bp duplex DNA with 3 nucleotides of either the translocating (A), 
or non-translocating (B) strand replaced by a PEG linker,  represented by an open box, causing a 
discontinuity in the phosphate backbone. The duplex was incubated with 11.25, 22.5, or 45 nM 
RPA and 15 nM X-WRN (lanes 2-4) for 20 min. under standard reaction conditions as described 
 92 
in Materials and Methods. The reactions were stopped with 11.5 µL ProtK-LiCl stop solution 
and precipitated as described in Materials an d Met hods for the PEG-containing Holliday 
Junctions. The circle denotes a TAMRA dye, and the diamond an Alexa 488 dye.  C. The 
percent remaining forked DNA for A and B, along with a control forked substrate that has no 
PEG linker and reacted under identical conditions to A and (B), graphed versus the ratio of RPA 
to X-WRN.  
 93 
 
Fig. 3.10. A 5’ PEG barrier on a Holliday Junction partially inhibits strand displacement. T 
denotes TAMRA fluorophore; C denotes Cy5 dye, A denotes Alexa488 dye. Black triangle 
denotes boiled lane and an open rectangle denotes a PEG linker.  2 nM HJbio-3’ (A) or 2 nM 
HJbio-5’ (B) is reacted with 15 nM X-WRN and 0, 22.5, or 45 nM RPA (lanes 2-4) for 60 
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minutes. The reactions are stopped by 11.5 µL ProtK-LiCl stop solution and precipitated as 
described in Materials and Methods The gel was then imaged as described above, and the Fig. 
shows the Alexa488 emission channel. C, quantitation of the HJbio-3’ and HJbio-5’ reactions in 
(A) and (B) as a function of RPA. Displaced helicase products are calculated as a mean 
percentage of the total DNA in the lanes versus the RPA:X-WRN ratio (see Materials an d 
Methods). The means and standard deviations are calculated from two to four independent 
reactions.  
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Fig. 3.11 Biotin-streptavidin does not further impede WRN on the 3’ end of HJ-5’. T denotes 
TAMRA fluorophore; C denotes Cy5 dye, A denotes Alexa488 dye and a trapezoid denotes a 
biotin tag. Black triangle denotes boiled lane And open rectangle denotes a PEG linker. (A) 2 nM 
HJ-5bio is reacted with 15 nM X-WRN and 45 nM RPA, with (lane5) or without (lane 3) 120 
nM streptavidin, under standard reaction conditions, and stopped by 11.5 µL ProtK-LiCl stop 
solution and precipitated as described in Materials and Methods. The gel was then imaged as 
described above, and the Fig. shows the Alexa488 emission channel. (B) Quantitation of the HJ-
 96 
5bio reactions in A. Displaced helicase products are calculated as a mean percentage of the total 
DNA in the lanes versus the RPA:X-WRN ratio (see Materials and Methods). The means and 
standard deviations are calculated from two to four independent reactions.  
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3.3.3 TRF2 protects telomeric arm HJ DNA from WRN strand displacement activity  
We hypothesized that TRF2 protects HJs from WRN activity since it stabilizes HR-like 
structures in the telomere from unwanted processing in vivo (1).  To test this we examined the 
non-telomeric HJA, and designed an HJ containing three telomeric repeats in two duplex arms in 
a trans configuration (HJT; Table 3.1 ).  A fully telomeric HJ construct would have been 
unstable due to spontaneous branch migration.  TRF2 pre-binding to the substrate decreased the 
percent of WRN HJT strand displacement in a dose-dependent manner from 49% to 20% (Fig. 
3.12A,D).  A TRF2 mediated decrease in exonuclease-degraded products was also observed 
(Fig. 3.13).  To determine whether TRF2 binding to the HJ core via its B-domain was 
responsible for WRN inhibition, we tested the non-telomeric HJA which lacks Myb binding 
sequences.  In sharp contrast to the telomeric arm HJT, pre-binding TRF2 to HJA did not alter 
WRN unwinding (Fig. 3.12B and D).  
 Next, we asked whether TRF2 interaction with the HJ arms via the Myb domain was 
responsible for TRF2 inhibition of WRN activity on the telomeric HJT.  To test this, a TRF2 
fragment with the N-terminal B domain deleted (TRF2∆B) was used.  The pre-incubation of 
telomeric HJT with TRF2ΔB exhibited no protective effect against WRN strand displacement 
activity (Fig. 3.12C and D).  These experiments indicate that TRF2 protects telomeric HJ DNA 
from WRN activity, but only on substrates containing binding sites for both the TRF2 B and 
Myb domains.  
A previous study reported that TRF2 protects an HJ with two telomeric repeats in the 
center from cleavage by HJ resolvase enzymes (84).  We tested the identical construct (HJM, 
Table 1) to determine whether TRF2 could provide a comparable protection from WRN strand 
displacement.  While HJM has binding sites for both the TRF2 Myb and B domains, the Myb 
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domain can only bind when the homologous core migrates to an extreme conformation with the 
two telomeric repeats in tandem on the same duplex arm (Fig. 3.13A).  In contrast to telomeric 
arm HJT, the pre-incubation of telomeric core HJM with increasing TRF2 concentrations did not 
alter the WRN strand displacement or exonuclease products (Fig. 3.13B,D).  To determine 
whether the lack of TRF2 inhibition resulted from WRN digestion into the Myb binding 
sequences, we repeated the experiment with the exonuclease-dead X-WRN.  However, TRF2 did 
not alter X-WRN strand displacement of HJM either (Fig. 3.13C, D). 
3.3.4 RAP1 does not alter TRF2 protection of telomeric arm HJ from WRN activity 
RAP1 is a member of the shelterin complex that binds TRF2, and is required along with TRF2 to 
protect telomeric ends from non-homologous end joining (NHEJ) (58;148).  Therefore, we asked 
if RAP1 also cooperates with TRF2 to prevent telomeric HJ displacement.  To test this, we pre-
bound telomeric arm HJT with 25 nM TRF2 and increasing RAP1 concentrations (0 to 50 nM) 
prior to WRN addition (Fig. 3.14B, lanes 2-5). While TRF2 inhibition of WRN was apparent, no 
significant difference in the amount of displaced HJ DNA was observed as a function of RAP1 
concentration (Fig. 3.14C).  Nor did we detect any modulation of WRN activity by RAP1 (50 
nM) alone (Fig. 3.14B, lane 6). 
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Fig. 3.12 TRF2 inhibits WRN unwinding of HJ substrates with telomeric arms.  A schematic of 
the telomeric arm (HJT) and non-telomeric HJA constructs are shown in panels (A-C).  Thick 
black lines denote (TTAGGG)3 repeats. T = TAMRA; C = Cy5; A = Alexa488. The 3’ end of 
the exonuclease-vulnerable T-oligo is highlighted as a dotted [Legend continues on next page.]   
line. Predicted TRF2 binding sites are indicated with the circle (B-domain) and the ellipse (Myb 
domain).  The substrates (0.5 nM) HJT (A) or HJA (B) were pre-incubated with either 0, 0.5, 5, 
12.5 or 25 nM TRF2 (A, lanes 2-6, respectively) and either 0, 0.5, 5 or 25 nM TRF2 (B, lanes 1-
4) in standard reaction buffer.  The reactions were initiated by the addition of 19 nM WRN and 
reacted for 1 hr at 37oC.  The reactions were run on 8% native gels for 1.5 hrs and visualized 
with a Typhoon Imager.  Scans of the Cy5 emission channel are shown in panels (A-B).  
Triangle indicates boiled substrate; M denotes a marker lane; arrows denote a triple-stranded 
species. (C) TRF2ΔB does not alter WRN unwinding of the telomeric HJ. The HJT (0.5 nM) 
substrate was pre-incubated with either 0, 0.5, 5 or 25 nM TRF2ΔB (lanes 2-5) prior to the 
addition of 19 nM WRN.  Reactions were for 1 hr at 37o
 
C, and were run on an 8% native gel.  
The scan from the Cy5 emission channel is shown. (D) Quantitation of HJ unwinding.  The 
percent of C-oligo present in the HJ substrate was quantitated as a function of total C-oligo DNA 
in the reaction as described in Materials and Methods and plotted against TRF2 or TRF2ΔB 
concentration. The values represent the means and standard deviations from at least three 
independent experiments. 
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Fig. 3.13 TRF2 inhibits displacement of T- and A- oligos. Thick black lines denote (TTAGGG)3 
repeats. T = TAMRA; C = Cy5; A = Alexa488.  The 3’ end of the exonuclease vulnerable T-
oligo is highlight as a dotted line.  Predicted TRF2 binding sites are indicated with the circle (B-
domain) and the ellipse (Myb domain).  The substrate was pre-incubated with either 0, 0.5, 5, 
12.5 or 25 nM TRF2 (lanes 2-6, respectively) in standard reaction buffer.  The reactions were 
initiated by the addition of 19 nM WRN and reacted for 1 hr at 37o
 
C.  The reactions were run on 
8% native gels and visualized with a Typhoon Imager.  A, TAMRA emission channel. B, 
Alexa488 emission channel.  M denotes a marker lane; arrows denote a triple-stranded species; 
“a” denotes exonuclease-degraded ssDNA. the two telomeric repeats in tandem on the same 
duplex arm (Fig. 3.8A).   
 102 
Fig. 3.14 TRF2 fails to inhibit WRN on an HJ with core telomeric repeats. (A) The HJM 
substrate has a 12 nucleotide homologous core composed of two (TTAGGG)2 repeats, denoted 
by a thick black line. Shown is the conformation with a fully branch migrated core.  The 
predicted TRF2 binding sites are indicated with the circle (B-domain) and the ellipse (Myb 
domain). C = Cy5 fluorophore.  The 3’ end of the exonuclease vulnerable C-oligo is highlighted 
as a dotted line. (B and C) The HJM substrate (0.5 nM) was pre-incubated with either 0, 0.5, 5, 
12.5 or 25 nM TRF2 (lanes 3-7) and  reacted under standard conditions for 1 hour with 25 nM 
WRN (B) or 40 nM X-WRN (C), respectively. The reactions were run on 8% native gels for 1.5 
hrs and visualized with a Typhoon Imager.  The scan from the Cy5 emission channel is shown.  
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Triangle indicates boiled substrate. (D) Quantitation of HJ unwinding (% Cy5 oligonucleotide 
displaced). 
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Fig. 3.15 RAP1/TRF2 complex inhibits WRN like TRF2 alone (A) Schematic of the HJT 
construct is shown.  Thick black lines denote (TTAGGG)3 repeats. T = TAMRA; C = Cy5; A = 
Alexa488. The 3’ end of the exonuclease vulnerable T-oligo is highlight as a dotted line. 
Predicted TRF2 binding sites are indicated with the circle (B-domain) and the ellipse (Myb 
domain). (B) The substrate was pre-incubated with 25 nM TRF2 and either 0, 12.5, 25, or 50 nM 
RAP1 (lanes 2-5) in standard reaction buffer.  The reactions were initiated by the addition of 19 
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nM WRN (lanes 1-6) and reacted for 1 hr at 37o
 
C.  Lane 6 contained 50 nM RAP1 and 19 nM 
WRN.  The reactions were run on 8% native gels and visualized with a Typhoon Imager.  Scans 
of the Cy5 emission channel are shown.  Triangle indicates boiled substrate; arrows denote a 
triple-stranded species. (C) Quantitation of HJ unwinding.  The percent of C-oligo present in the 
HJ products was quantitated as a function of total C-oligo DNA as described in Materials and 
Methods and plotted against RAP1 concentration.  Products were quantitated as a function of 
total C-oligo DNA as described in Materials an d Met hods and plotted against the TRF2 
concentration.  The values represent the means and standard deviations from three separate 
experiments.  
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3.3.5 TRF2 exhibits increased binding to telomeric HJ compared to non-telomeric HJ  
We hypothesized that the mechanism by which TRF2 protects HJ DNA from WRN activity is 
via binding both the HJ core and the telomeric repeats in the HJ arms.  Therefore, we predicted 
that TRF2 should exhibit increased binding to a telomeric HJ, compared to a non-telomeric HJ, 
since both TRF2 B and Myb domains can engage the telomeric HJ.  We performed 
electrophoretic mobility shift assays to compare TRF2 binding to non-telomeric HJA and 
telomeric HJT and HJM.  The migration of all three substrates was retarded by TRF2 in a protein 
concentration dependent manner (Fig. 3.17A, lanes 1-15).  TRF2 shifted HJT to a higher 
migrating species compared to HJA or HJM, suggesting that more TRF2 molecules may be 
bound to the telomeric arm HJT substrate (Fig. 3.17A, lanes 5, 10, and 15).  A shifted HJ/TRF2 
complex was apparent at 50 nM TRF2 for HJT and HJM, but was not detected until 125 nM 
TRF2 for HJA (Fig. 3.17A, lanes 3, 8, and 13).  The binding curves for the HJT and -M 
substrates showed a 50% shift by about 50 nM TRF2, compared to about 100 nM for HJA (Fig. 
3.17C). 
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Fig. 3.16 RPA does not displace forked duplex or HJ substrates. (A) Reactions contained a 31-bp 
forked duplex (0.5 nM) with a biotinylated nucleotide (inverted trapezoid) on the 
nontranslocating strand. The forks were constructed by annealing oligonucleotides bio-1 and 2 
(Table 1). T = TAMRA.  The duplex length (bp) on either side of the biotinylated nucleotide is 
shown.  The substrate was pre-incubated 0 (lanes 1) or 45 nM RPA (lane 2). Reactions were for 
60 min at 37oC, and were run on an 8% native polyacrylamide gel for 1.5 hrs and visualized with 
a Typhoon imager.  The gel scans show the TAMRA emission channel. Boiled substrate (lane 3). 
(B) The HJbio-end substrate has a biotin tag at the 3' end of the A-oligo.  T = TAMRA; C = Cy5; 
A = Alexa488; inverted trapezoid denotes a biotin moiety. The substrate was pre-incubated with 
0 (lanes 1) or 45 nM RPA (lane 2). Boiled substrate (lane 3). The gel scans show the Cy5 
emission channel. Reactions were for 60 min at 37o
polyacrylamide gel for 1.5 hrs and visualized with a Typhoon imager  
C, and were run on an 8% native  
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Fig. 3.17 TRF2 and TRF2ΔB exhibit increased binding to telomeric HJ constructs. The 
substrates (5 nM)  telomeric arm HJT (lanes 1-5), non-telomeric HJA (lanes 6-10), and telomeric 
core HJM  (lanes 11-15) were reacted with either 0, 5, 50, 125 or 250 nM TRF2 (A) or TRF2ΔB 
(B), respectively, in standard reaction buffer supplemented with 5% glycerol for 20 min at 24º C. 
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The reactions were loaded on a 1% 0.5X TBE agarose gel and electrophoresed for 1 hour at 140 
V in 4ºC. Gels were scanned on a Typhoon Imager and visualized in the Cy5 channel. (C) 
Quantitation of the binding reactions.  The percent of bound substrate was calculated as a 
function of total DNA in the Cy5 channel and plotted against TRF2 or TRF2ΔB concentration. 
Values represent the means and standard deviations from 2 or 3 independent reactions. 
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3.4 DISCUSSION 
The WRN helicase/exonuclease protein is a RecQ family helicase that displaces HJ DNA, 
consistent with a cellular function in restoring stalled replication forks and disrupting 
homologous recombination intermediates  (7;11;44;133).  Previous studies showed that TRF2 
protects telomeric HJ DNA at the t-loop/D-loop from cleavage by endonucleases in vivo (37;83) 
and in vitro (84), but TRF2 protection from HJ displacement was not previously reported.  Our 
results showed that TRF2  protects HJ DNA from WRN-mediated strand displacement, but only 
if TRF2 can simultaneously bind the HJ with both of its DNA-binding domains: 1) the B domain 
which binds HJ DNA regardless of sequence, and 2) the Myb domain which binds telomeric 
duplex DNA (55;56).  This is in contrast to previous research which showed that the B-domain is 
sufficient for protecting  HJ DNA from enzymatic cleavage (84). 
3.4.1 WRN mechanism of HJ strand displacement 
The novel multiplex imaging of HJ strands in this study allowed us to elucidate mechanistic 
details of WRN strand displacement that would not be possible by labeling one strand of the 
construct as done previously.  Our data are consistent with a mechanism by which WRN 
displaces HJs starting from the HJ center and processing outward.  Specifically, on our substrate 
we propose WRN translocates 3’ to 5’ along the T-oligo from the center toward the 5’ TAMRA 
label at the blunt end (Fig. 3.6).  The first evidence was that a biotin-streptavidin barrier placed 
on the T-oligo at the HJ core led to a two-fold reduction in single stranded A- and T-oligo 
products (Fig. 3.6).  Secondly, the barrier at the HJ core also induced some trapping of the A- 
and T-oligos into novel 2-way and 3-way products that lacked the C-oligo (Fig. 3.7) after WRN 
unwinding.  This suggests that the biotin-streptavidin barrier inhibits WRN processivity along 
the A-T arm (Fig. 3.6E,I) and the T-unlabelled arm (Fig. 3.6E,III) depending on the barrier 
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location in the specific mobile core conformation, but not along the C-oligo arms which never 
contains the barrier in any core conformation.  Thirdly, if WRN helicase initiated unwinding 
from an HJ arm blunt end and moved inward, then a barrier on the 3’ end of a strand should 
block WRN helicase.  However, such a barrier had no effect on strand displacement, nor did it 
lead to novel “trapped” products (Fig. 3.8).  In summary, although the WRN exonuclease can 
initiate at an HJ blunt end (Fig. 3.2), the helicase does not, and thus, could not efficiently 
circumvent a protein bound to the HJ core such as TRF2.   
 Our results with the HJ barrier containing constructs corroborate electron micrographs 
showing WRN bound to the HJ center (142) and a protein-DNA cocrystal of RecG bound to a 
model replication fork (149).  RecG and WRN belong to the SF2 superfamily of helicases (150), 
and RecG converts HJs into forked substrates and then into ssDNA similar to WRN (151)(11) 
(Fig. 1).  The crystal structure shows a RecG monomer bound to the junction of a model 
replication fork (149), which resembles the junction of a regressed replication fork or HJ.    
3.4.2 Mechanism of TRF2 inhibition of WRN telomeric arm HJ strand displacement  
Our data help resolve a paradox of TRF2-WRN interactions.  WRN is required for telomere 
preservation (18;152) and TRF2 stimulates WRN helicase on forked substrates (28), yet TRF2 
prevents WRN promotion of aberrant telomere t-loop/D-loop HR cleavage (83).  The WRN 
requirement for telomeric circle formation when the TRF2ΔB mutant is overexpressed (83) 
suggests TRF2 inhibits WRN-mediated branch migration at the telomere t-loop/D-loop.  Here we 
report that TRF2 modulation of WRN activity is highly substrate dependent.  At a 50:1 TRF2:HJ 
molar ratio, prebound TRF2 inhibited WRN strand displacement of an HJ with two telomeric 
arms by 50%, but unwinding of the non-telomeric HJ was unaffected (Fig. 3.7).  At this same 
ratio nearly 100% of both the telomeric arm and non-telomeric HJs are bound by TRF2 (Fig. 
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3.17), consistent with previous studies (56).  This shows that TRF2 substrate binding via the B 
domain only (non-telomeric HJ) provides no protection against WRN activity (Fig. 3.7B).  
Consistent with this, the TRF2 Myb domain alone cannot protect the telomeric arm HJ (Fig. 
3.7C) or a telomeric fork (28) (the B-domain does not bind a fork), from WRN activity.   
 The mechanism of TRF2 protection against HJ cleavage differs from protection against 
WRN HJ strand displacement.  A previous study showed that a 40:1 TRF2:HJ ratio reduced 
enzymatic HJ cleavage by 80% on an HJ with two telomeric repeats in the mobile center, and 
that protection was primarily via the B domain (84).  With this same substrate (HJM, Fig. 3.9A) 
even a 50:1 molar ratio of TRF2 to HJ provided no protection against WRN helicase activity 
(Fig. 3.9B).  One explanation for this difference is that while this HJ has binding sites for both 
the TRF2 B and Myb domains, both probably cannot bind at once.  The footprint of a single Myb 
domain is YTAGGGTTR (153), thus, a TRF2 homodimer cannot bind this substrate with both 
Myb domains at once.  A single Myb domain can bind only if the HJ mobile core has migrate to 
one extreme (Fig. 3.9A), but it may not be sterically possible for the B domain to bind as well.  
Consistent with this, when the HJ-specific TRF2 B-domain was deleted the percent of TRF2 
bound telomeric core HJM was half that of telomeric arm HJT (Fig. 3.12C).  Protection against 
WRN helicase activity requires both TRF2 domains to be bound, not just the B-domain as is the 
case with protection against cleavage.  Poulet and colleagues reported that the TRF2 B-domain 
“melts” the mobile center of the HJ, creating an altered conformation that HJ cleaving enzymes 
cannot recognize (84).  A melted HJ center would hardly discourage a helicase, particularly one 
that initiates displacement at the HJ center, such as WRN (Figs. 3.5-3.6).     
 Several potential models might explain the TRF2 inhibition of WRN activity on 
telomeric arm HJ.  In stark contrast to a biotin-streptavidin complex at the HJ core (Fig. 3.5), a 
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core bound TRF2 B-domain does not inhibit WRN (Fig. 3.11), which rules out a TRF2 steric 
inhibition model.  Since TRF2 interacts with WRN via the B-domain (83), we would have 
expected inhibition on a non-telomeric HJ, which was not the case (Fig. 3.7B).  Thus, TRF2 
inhibition of WRN telomeric HJ activity is unlikely to be mediated by protein-protein 
interactions, which is the proposed mechanism for p53 inhibition of WRN HJ activity (154).  
Instead, we favor a model whereby both TRF2 DNA binding domains must bind the HJ 
simultaneously in order to “lock down” the substrate into a conformation that is unfavorable for 
WRN strand displacement or branch migration activity.  While HJ constructs are often depicted 
as square-planar shapes, crystallographic evidence indicates that duplex arms can stack on one 
other (155).  Single-pair FRET and structural studies showed that HJ DNA alternates between 
the stacked conformation and an open square-planar conformation, which is the form that branch 
migrates and is favored by proteins that promote HJ migration (149;156-158).  Simultaneous 
interaction of TRF2 with the core and the telomeric arms might promote the stacked arm 
conformation, perhaps via TRF2 molecules bound to separate arms interacting with each other 
through dimerization or higher oligomeric forms.  Consistent with this, the telomeric arm HJ 
(HJT) exhibited a slower TRF2-bound migrating species than either the non-telomeric (HJA) or 
telomeric core HJ (HJM) (Fig. 3.12A) which likely reflects a larger oligomeric complex.  Our 
results agree with previous studies that show TRF2 has higher affinity for HJs with telomeric 
repeats, compared to non-telomeric HJs (84).  Therefore the number of accessible telomeric 
binding sites is important for TRF2 HJ binding, and this correlates with protection from WRN 
activity.  We suggest that a fully telomeric HJ would enjoy greater TRF2 protection since there 
are far more TRF2 binding sites compared to our hybrid constructs.  
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3.4.3 Role for RAP1/TRF2 complex in protection against HJ displacement 
The current study extends our understanding WRN function in the context of the mechanism of 
action of shelterin proteins at telomeres. While RAP1 forms a complex with TRF2 and is 
necessary to protect telomere ends from NHEJ (58), it does not alter TRF2-mediated inhibition 
of WRN on an HJ containing telomeric arms (Fig. 3.9).  RAP1 binds to the central TRF2 
dimerization domain (148), whereas WRN interacts with the TRF2 N-terminal B domain (83).  
Thus, our biochemical data is consistent with cellular studies since RAP1 should still localize to 
telomeres with TRF2∆B expression but offers no protection against aberrant HJ cleavage (83), 
and RPA1 does not localize to telomeres in the absence of TRF2 when protection against 
aberrant NHEJ is lost (159).  Neither does RAP1 increase the binding affinity of TRF2 for 
telomeric DNA (160).  Therefore, RAP1-mediated protection against NHEJ probably has no 
mechanistic basis in protection against WRN activity.  
3.4.4 The Yin and Yang of WRN at telomeres 
Telomeres are dynamic structures regulated by the interplay of multiple proteins composing both 
the shelterin complex and the numerous proteins that interact with shelterin.  Many of these 
proteins become deleterious for telomere maintenance if dysregulated (1;161).  WRN is 
necessary to prevent telomeric circle formation in telomerase-positive cells, but without full-
length TRF2, WRN itself is required for telomere circle formation (45). In yeast, the TRF2 
ortholog Taz1 similarly protects against telomere loss mediated by the WRN ortholog Rqh1 
(162) in conjunction with the RPA ortholog Rad11 (163).  Telomere preservation is restored in 
Taz1 mutants by either mutating a SUMOylation site on the Rgh1 protein (162) or by 
overexpressing the shelterin protein POT1 (163).  By demonstrating that TRF2 can protect 
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telomeric HJ DNA from WRN activity, our study provides a mechanistic basis for the cellular 
studies showing that TRF2 or Taz1 regulate WRN or Rqh1 activity, respectively.  
 In summary, we verified that WRN displaces HJs from the center and progresses 
outward, and that this strand displacement occurs simultaneously with WRN exonuclease 
activity. We found that TRF2 can protect telomeric HJs from WRN activity only if both TRF2 
DNA binding domains simultaneously engage the HJ core and the arms.  Our biochemical 
studies provide an explanation for the cellular studies that indicate WRN adversely affects 
telomere processing in the absence of TRF2 (83).  Understanding how shelterin accessory 
factors, such as WRN, are regulated by specific shelterin proteins is critical for defining 
mechanism of telomere loss and preservation, and the consequences of dysregulation for human 
disease.    
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The shelterin complex and telomere-associated proteins must modulate non-canonical 
DNA structures in order to maintain telomeric and genomic stability. While telomere length has 
captured the public’s attention as a cause for aging, cellular senescence may occur as a result of a 
single telomere undergoing sudden shortening, thereby triggering an unwanted DNA damage 
response. This study sought to elucidate the DNA structures and mechanisms underlying the 
known cellular mutational and knockout models for the shelterin and telomere-associated 
proteins. Our goals were to: (1), find how G4 DNA is arranged on long, physiologically relevant 
telomeric substrates, (2), elucidate how POT1 competes with G4 folding on long telomeric 
substrates, (3), determine the mechanism of WRN displacement of HJ DNA, and (4), determine 
whether TRF2 protects HJ DNA from WRN displacement.   
 
4.1 G4 DNA IS UNDERFOLDED AND FORMS BEADS ON A STRING ON LONG 
TELOMERIC ssDNA 
The literature on G4 DNA formation is unclear on how G4 DNA is arranged on long, 
physiologically relevant telomeric ssDNA. One CD study implied that G4 DNA folds to 
maximize the number of quadruplexes that can be folded on a substrate (78), creating a beads on 
a string arrangement of individual quadruplexes separated by linker ssDNA (Fig. 2.1). In 
contrast another group found that G4 DNA formation (as measured by CD) was enthalpically 
penalized by progressively longer telomeric substrates (77), implying that even if the 
quadruplexes formed beads-on-a-string, they might not fold into the maximum amount of G4 
DNA (79).  
We have used AFM to visualize and quantify G4 DNA on long telomeric ssDNA. We 
used the length of the G4 DNA (defined as being over 1 nm in height) and demonstrated that 
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(TTAGGG)16 molecules on average have twice the length of G4 DNA as (TTAGGG)8 and 
(TTAGGG)4 molecules (Fig.2.2D). We confirmed that under our deposition conditions that 
ssDNA and duplex DNA controls did not form structures over 1 nm. We investigated why 
(TTAGGG)16
A recent study used exonuclease degradation to show that when the 5’ end of a telomeric 
substrate is bound to a flanking sequence, G4 DNA formation is favored at the 3’ end, with the 
probability of G4 DNA formation decreasing as one moves inward (164). We therefore 
hypothesize our 34 bp stem on the 5’ end of the telomeric ssDNA inhibits G4 folding on the 
neighboring 2-3 repeats, which is why the folding profile of the G4 DNA resembles a 13- or 14-
repeat substrate more than one with 16 or even 15 repeats.  
  was underfolded by a factor of two with a simple combinatoric model, showing 
that as an ensemble of all possible conformations, that 2 quadruplexes were the most probable. 
However, our model predicted a nearly equal quantity of triple-quadruplex forming molecules, 
which was not the case. We found that our folding profile matched folding curves for ssDNA 
composed of 13 or 14 repeats better than 16 or 15.  
Due to the limitations of the AFM resolution (see below), we measured overall G4 DNA 
length, but were still able to visualize substrates with 2-3 peaks (Fig. 2.3 ), supporting a beads-
on–a-string structure of individual quadruplexes linked by ssDNA. Had the guanine tetrads 
aligned themselves into a more rigid array, we would have expected a taller (i.e., less deformable 
by the AFM probe) structure with no peaks or surface features like the G-wire.  
One may define the conditions that permit our system to resolve individual peaks. 
Bustamante and Keller defined an equation (cited in 88) relating the minimum resolution d to the 
radius of the AFM tip and the "dimple depth" between objects (which is 0.2 nm in the case of 
defining G4 peaks).  
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where d is the resolving distance, z is the “dimple”, h is the difference of the height 
between the peaks and R  is the radius of the tip.  This assumes the case where the resolution d is 
greater than hR∆2 . Using the manufacturer's (NanosensorsTM
h∆
) specifications, the tip radius is 
7 nm, and assuming the peaks are the same height ( =0), the resolution is 3.6 nm. The G4 
DNA structure in Fig.1.5 is 4.4 nm along its longest axis, which puts G4 DNA at the edge of the 
system’s capabilities even when the tip is not damaged or blunted. 
 We used Pymol to make two copies of a G4 DNA structure (Protein Data Bank ID: 
2JPZ) and bond the two copies together (Fig. 1.5), providing a model of what a double-
quadruplex beads on a string structure would look like. Using the distance function on Pymol, 
the distance between the midpoints of the two quadruplexes is about 2.2 nm, below the 
resolution of the ideal calculated above (3.6 nm) by 1.4 nm. Following Hansma and 
colleagues(107), ssDNA has a length of 0.2-0.5 nm per nucleotide, depending the degree of 
extension or nonspecific folding. Therefore a resolution of 3.6 nm requires a gap equivalent of 3-
7 nucleotides in addition to the 3 nucleotide (TTA) linker already present between the 
quadruplexes. When we resolve two peaks, there must be at least 1.5 telomeric repeats present 
between the quadruplexes, though there may be more since the ssDNA may not be fully 
extended. Since the mean interpeak distance of G4 peaks on Tel16 was 20 nm, this translates to 
roughly 7 telomeric repeats, assuming that they are fully extended. Since a maximally folded 
(TTAGGG)16
 
 has only TTA linkers and no “spare” telomeric repeats to use as spacer, one would 
not expect to see four distinct peaks under the above criteria for determining peaks.   
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4.1.1 POT1 is a steric driver on long telomeric tails 
POT1 was shown to passively compete with G4 folding on short telomeric substrates by binding 
to spontaneously unfolded telomeric ssDNA and thus preventing the DNA from refolding(103). 
POT1, however, was never reported on longer, more physiologically relevant telomeric 
substrates, and until our own results the distribution and structure of the G4 DNA on the longer 
telomeric substrates were themselves mysteries.  
We found that POT1 competes with and destabilizes G4 DNA, with the average length of 
G4 DNA being 12.5 nm, half of the G4 DNA formed by (TTAGGG)16 alone and with the 
population of G4 DNA reduced to 22% of the molecules recorded. Interestingly, POT1 binds 
(TTAGGG)16 and the non-G4 forming control substrate in a roughly equal distribution of 
lengths, as depicted in Fig. 2.10E . This suggests that POT1 can destabilize G4 DNA, what we 
dubbed a “steric driver”, since otherwise POT1 would be limited to unfolded parts of the 
(TTAGGG)16
 The steric driver effect may in fact be an emergent cooperative effect, as a bound POT1 
would destabilize existing G4 DNA and thus open more ssDNA to POT1 binding, but one would 
have to test a range of POT1:DNA ratios to determine this. One limiting factor in AFM is that if 
one “carpets” the mica with too much protein, it becomes hard to determine whether individual 
POT1 molecules are on the same substrate or not. 
 molecule, while in the control substrate the whole length of the ssDNA is 
available for binding. 
4.1.2 Future directions  
The WRN helicase/exonuclease unwinds G4 DNA and localizes to the telomere during S-phase.  
WRN is currently not at the level of purity necessary for AFM, since there are breakdown 
products contaminating the full-length WRN. However, a “double-tag” vector for WRN, 
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employing both hexahisitidine and FLAG affinity tags instead of just hexahistidine(144), 
promises to increase the purity of WRN preparations.  An AFM-suitable WRN sample would 
provide an important structural underpinning to our biochemical characterization of WRN action 
on HJ DNA (4.3) with the added advantage that AFM provides a 3D image without the use of 
heavy metal contrast agents, such as with a recent electron microscopy (EM) study of WRN 
binding to HJ DNA (142). Another route to study WRN on G4 DNA is Förster Resonance 
Energy Transfer, discussed in Chaper 4.2, and unlike AFM is better optimized for mechanistic, 
time-dependent details of helicase activity.  
POT1 competes with RPA binding on telomeric, G-rich ssDNA, where RPA can act as a 
DNA damge reporter while POT1 suppresses ATR (165). Since POT1 has the greater affinity for 
telomeric ssDNA than RPA, there is a higher POT1:RPA ratio at telomeres in wild type 
cells(42), but the knocking down of POT1 expression would increase the signal to trip the repair 
machinery. A structural study using AFM could demonstrate how the G4 DNA landscape in 
(TTAGGG)16  is altered by the more physiologically relevant combination of RPA and POT1, 
rather than just POT1. We already have a physiologically relevant model of the telomeric 3’ tail 
in our (TTAGGG)16
Quantum dots (Qdots) have been conjugated via two antibodies to UvrB and used to 
demonstrate UvrAB complex formation on nicked DNA(111). While the Qdots were successful 
in preserving the binding functionality of UvrAB, their large size (radius ~20 nm)(111) might 
create artifacts with RPA-POT1 coating of a DNA strand. A recent paper on thiol-functionalized 
2 nm gold particles might provide a better route for studying ssDNA-binding proteins on the 
Tel16 substrate(166). 
 construct, but would need a means to discriminate between the two proteins. 
Quantum dots and gold nanoparticles conjugation to the proteins would provide one such option. 
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A fringe benefit of the gold nanoparticles is that their regular shape could be of service 
for deconvoluting the original shapes of the molecules scanned by the AFM.  The image viewed 
on the computer screen shows the convolution of the shape of the protein plus that of the tip 
shape. The tip shape is usually a matter of conjecture unless one takes the trouble to put each tip 
under a scanning electron microscope to record its shape. Even then, as soon as the tip comes 
into use it will be blunted. By having a gold standard in the sample with a well-defined shape, it 
is possible to back-calculate the shape of the tip, and thus, one could be able to properly 
deconvolute the shapes of the other non-gold molecules in the image. 
 
4.2 TRF2 PROTECTS HJ DNA FROM WRN ACTIVITY IF BOTH DOMAINS ARE 
BOUND 
The shelterin protein TRF2 plays a multifaceted role in protecting the telomere. It suppresses the 
non homologous end joining (NHEJ) of double strand break repair at the telomere by localizing 
the NHEJ-suppressor RAP1 to the telomere(83), and is also known to suppress sudden telomere 
loss mediated by Holliday Junction cleaving enzymes. The latter phenomenon is dependent on 
WRN, as cells with knocked down WRN protein do not undergo telomere loss when TRFΔB is 
expressed in the cell(83). We verified that TRF2 inhibits WRN-mediated displacement of HJ 
DNA if TRF2 could simultaneously bind the HJ with both DNA binding domains. Using a novel 
fluorophore-based assay, we also demonstrated that WRN helicase initiates strand displacement 
in the center of the HJ and moves outward.  
 While the B domain of TRF2 primarily conferred HJ protection against GEN1-mediated 
cleavage(84), the B domain alone cannot protect HJ DNA from WRN activity, as evidenced by 
the HJA substrate, which can only be bound via the B-domain and is totally unprotected by 
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TRF2 (Fig. 3.12B). Similarly the Myb domain alone conferred no protection to HJT, which has 
Myb binding sites in two arms (Fig. 3.12C ). While the HJM substrate, with two telomeric 
repeats in the center, was protected by TRF2 from GEN1, it was not protected with WRN, either 
with or without exonuclease (Fig. 3.14). Since TRF2 can bind HJM with only one domain at a 
time, and only one TRF2 monomer can bind the telomeric repeats at one of the extremes of 
branch migration (Fig. A), the HJM cannot be bound simultaneously by both TRF2 domains. 
The simultaneous binding of HJT by both TRF2 domains (with dimers being able to bind both 
arms) is suggested in the EMSA results, where HJT is shifted to a slower migrating band than the 
other HJ substrates studied (Fig. 3.17).   
 We also elucidated the mechanism of WRN-mediated strand displacement by means of 
biotin-streptavidin barriers one of the oligonucleotides making up the Holliday Junction. A 
centrally placed biotin-streptavidin barrier trapped two fluorophore-labeled oligonucleotides as 
forked and three way species, with diminished liberation of ssDNA species (Fig. 3. 6). In 
contrast, a biotin-streptavidin barrier on the 3’ end of one oligonucleotide (where WRN might 
load if it initiated unwinding from the edge) had no effect on HJ DNA displacement (Fig. 3.7).  
4.2.1  Future directions for WRN and telomeric HJ DNA 
We proposed a mechanism for TRF2-mediated HJ protection by altering the geometry such that 
the HJ is not readily branch-migrated. Single molecule FRET is a method that would readily test 
this model. In a proposed model HJ with telomeric-repeat containing arms in trans arrangement 
(Fig. 4.1), the HJ can be either in a square planar (I) or stacked (II) conformaitons. In (I), a donor 
dye (green) remains distant from the acceptor (red), so the latter does not emit. However, if the 
trans arms are brought close together (II), such as via TRF2 binding and multimer coordination, 
the acceptor will emit.  Care must be taken to avoid the “quenching” effects of G-rich DNA with 
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fluorophores, where the excitation energy of the dye is transferred to the guanine(167). Fig. 4.2 
depicts one such precaution by placing the fluorophores on the C-rich arms instead of the G-rich. 
The ends of the telomere-containing arms may also have a brief non-telomeric T/A sequence 
right at the edge in order to protect the signal. 
The HJ constructs in this study used “fluid” or homologous centers permitting branch 
migration. Researchers have already used FRET to study branch migration and HJ arm stacking 
simultaneously(149;156-158).  Thus one may monitor both the effect of TRF2 on HJ geometry 
and WRN on branch migration. Single molecule FRET would provide a powerful model system 
for elucidating the mechanism TRF2 at telomeric HJ DNA, and also further exploring the 
mechanism of WRN-mediated branch migration of HJ substrates.  
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Fig. 4.1 Schematic of FRET-based assay for HJ geometry and branch migration. An HJ construct 
with two telomeric-repeat (heavy black denotes G-rich strand) arms in trans has  donor (green) 
and acceptor (red) fluorophores on the opposing arms. A square planar, branch-migrating 
conformation (II) will have a low FRET output. When HJ arms associate with the arm across 
from them in a stacked confirugation, FRET efficiency will be high (II). Biotin tags to link the 
construct to the flow cell surface have been omitted for clarity. 
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4.3 SINGLE PAIR FRET ANALYSIS OF G4 DNA FORMATION AND MODULATION  
Our studies of G4 DNA focused on a population of quadruplexes on long telomeric tails. In 
addition to POT1, however, the RecQ helicases BLM and WRN as well as the RecD helicase 
FANCJ actively unwind G4 DNA. Biochemical studies have tested these helicases against 
intermolecular quadruplexes formed from two or more oligonucleotides, with one of the 
oligonucleotides radiolabelled(30;128). The G4 DNA most likely encountered in human 
telomeres is intramolecular, however, such intramolecular quadruplexes defy bulk biochemical 
studies since they can readily “snap back” into G4 DNA after being unwound by a helicase. 
Single pair Forster Resonance Energy Transfer (spFRET) utilizes a non-radiative transfer of 
energy from a donor dye to an acceptor, the transfer of energy is inversely proportional to the 
sixth power of the distance between the dyes, providing a real-time “molecular ruler” to track 
folding of G4 DNA. Single-pair FRET has been used to study G4 DNA folding at the single-
molecule level, however it was done on a construct where the telomeric DNA was in a reversed 
orientation, with the telomeric ssDNA being GGG(ATTGGG)3 rather than (TTAGGG)3
 
GGG, 
perhaps as a result of the contemporary limitations on synthesizing an oligonucleotide with a 
biotin at one end(123). Furthermore, the authors did not examine G4 DNA folding in the context 
of telomere-associated proteins like POT1 or WRN(123). We constructed a FRET substrate that 
has the telomeric ssDNA in the correct orientation. As with the previous studies, we have a 
duplex stem, with the complementary strand having the donor dye (TAMRA), and the 5' end of 
the telomeric repeat-containing oligonucleotide having a biotin tag, used to fix the construct to 
the surface of the flow  
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Fig. 4.2 Schematic of the TelG4 oligonucleotide in both its unfolded (above), folded (middle) 
conformations. The sequences and placement of fluorophores and biotin are indicated at bottom. 
Triangle denotes biotin in upper and middle schematics. “+” signs denote cations (e.g., K+
 
) 
which are necessary for folding and stabilization of the individual tetrads. Courtesy of Matthew 
Fagerburg. 
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cell described below. The acceptor dye (Cy5) is on the end of the telomeric repeats, but is not 
covalently linked to the terminal guanines, which can quench the signal of the acceptor dye. 
Total Internal Refraction FRET (TIRF) uses an inverted microscope and a flow cell 
created from a plastic cover and a quartz slide with a thin spacer in between. The flow cell is 
illuminated above by evanescent light from a prism that is illuminated by total internal refraction 
(TIR) from a laser source (laser wavelength is 532 nm for our apparatus). The evanescent light 
"leaking" from the TIR at the prism boundary excites fluorophores in the flow cell without 
creating excessive background illumination. The flow cell surface is covered with biotinylated 
bovine serum albumin (BSA) and streptavidin, to which our construct (which has a biotin tag) 
binds. The fluorescent emissions are collected by the objective and split into two channels by a 
dichroic mirror, one each for the donor and acceptor emission spectra, which are quantitated and 
correlated with each other. 
4.3.1 Results 
We have verified that our oligonucleotide transitions from a low FRET state with no potassium 
ions to a high FRET state in the presence of potassium (100 mM), corresponding to the folded 
quadruplex. We incubated 50 μL of 3 pM FretG4 in standard reaction buffer (40 mM Tris, pH 
7.5, 1% beta-mercaptoethanol, 0.8 % glucose, 0.1 mg/mL glucose oxidase, and 0.02 mg/mL 
catalase) in a reaction chamber and flushed the reaction volume (50 μL) after 5 minutes with 
standard reaction/scavenger buffer before imaging. Data were collated at 30 millisecond intervals 
for 90 seconds. Intensities over a 1 second period were averaged and the resulting normalized 
FRET efficiencies (Eacceptor/Edonor) were calculated on MatLab (Mathworks, Natick, MA) and 
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plotted as histograms on Excel (Fig. 4.4). We found that a high FRET efficiency (0.8) was 
achieved when KCl was present, consistent with G4 DNA folding (Fig. 4.4A,B). 
To test whether POT1 inhibited G4 folding, we prepared a sample with standard reaction buffer, 
100 mM KCl and incubated 20 nM POT1 with 3 pM FretG4 substrate for 20 minutes at room 
temperature before injecting into a flow cell and visualizing. We found that the unfolded peak in 
the histogram reappeared (Fig. 4.4C), indicating that there was small population of unfolded 
DNA under conditions where all DNA was folded initially. The relatively small response from 
such a massive quantity of POT1 is perhaps attributable to the adsorption of POT1 to the BSA 
coated surface. 
We verified that POT1 bound TelG4 under bulk conditions using a Cary Eclipse 
fluorimeter (Varian, Palo Alto, CA). Following ionic concentrations in which POT1 binding is 
known to occur(103), we incubated 10 nM FretG4 DNA in 40 mM Tris, pH 7.5, 1 mM MgCl2
 
, 
15 mM NaCl, 50 mM KCl, 1% beta-mercaptoethanol,  and 5% glycerol with or without 30 nM 
POT1 for 30 minutes. We found a reduction in the 587 nm emission peak, signifying less G4 
DNA folding and thus a lower FRET efficiency with a far lower POT1:DNA ratio than in the 
single molecule studies. Further work is necessary to determine whether the salts, the 
temperature or the surface conditions of the spFRET led to the effectively lower POT1 affinity 
for G4 DNA in the single molecule FRET relative to the bulk study. The use of polyethylene 
glycol (PEG) preparations instead of BSA to coat flow chambers may also prevent protein 
adsorption, but we must figure out the proper PEG formulation and coating protocol. 
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Fig. 4.3 Schematic of single molecule, wide field FRET microscopy of G4 DNA. A, Schematic 
of the TIRF assembly on an inverted microscope, showing the prism, laser source, flow cell and 
objective. B, Schematic of laser light refracting off the quart slide, with an evascent field exciting 
dye-labelled constructs bound to the surface underneath. C, Example data showing the 
microscopic wide field images with the acceptor and donor emission channels from the same part 
of a slide.  Courtesy of Matthew Fagerburg. 
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In order to elucidate the mechanism of WRN unwinding of G4 DNA, we had to verify 
that WRN was active under FRET conditions. We have verified that WRN is active under 
modified FRET conditions at room temperature. WRN was titrated in the concentrations  with 
0.5 nM forked substrate (Tel3/4) with 22 bp of duplex DNA as well as a 3’ and 5’ tails which 
was radiolabelled and annealed as described in (33).  WRN was reacted at room temperature in 
40 mM Tris pH 7.5, 4 mM MgCl2
 
, 0.1 mg/mL BSA, 0.26% glucose, 2 mM ATP, 0.067 mg/mL 
glucose oxidase, 0.013 mg/mL catalase, and 100 mM KCl. We titrated WRN against beta-
mercaptoethanol (BME) concentrations as noted in (Fig. 4.6). BME is a free radical scavenger 
that protects against dye-blinking, but can also denature proteins and degrade activity. DTT was 
omitted to avoid noisy FRET imagery, probably due to DTT precipitates in the solution. We 
found that WRN activity against Tel3/4 was increased with greater quantities of BME, probably 
because it protected WRN against oxidation in the absence of DTT. Therefore WRN is likely to 
be active under FRET conditions. 
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Fig.4.4 G4 DNA folding requires KCl but is partially inhibited by POT1. 3 pM FretG4 is reacted 
under standard conditions alone (A), with 100 mM KCl (B) or with 100 mM KCl and 20 nM 
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POT1 (C) before quantitating by spFRET. Histograms were created as described in Materials 
and Results. 
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Fig. 4.5 POT1 reduces FRET signal attributable to G4 DNA folding. Fluorescence levels of G4 
DNA in bulk fluormetry buffer alone (blue) or in addition to POT1 after 30 minutes of 
incubation at room temperature (green) are scanned in a Cary Eclipse fluorimeter.  
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Fig. 4.6  WRN is active at room temperature with FRET conditions. 0.5 nM Tel3/4 substrate (0.5 
nM) was incubated with 0.25 (lanes 4,7,10), 0.5 (lanes 3,6,9), or 1 nM (lanes 2,5,8) WRN 
incubated at room temperature for 30 min in 0 (lanes 2-4), 50 (lanes 5-7) , or 100 mM (lanes 8-
10) BME . Reactions were stopped with 11.5 μL stop dye(33), and run on a 12% native 
polyacrylamide, 1X TBE, 0.1% SDS gel at 150 V for 90 minutes. Gel was exposed overnight 
and scanned on a GE Storm. 
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4.4 CONCLUSIONS 
The human telomere is critical for maintaining the stability of genomic DNA. Even non-dividing 
cells must be protected from unwanted DNA damage responses, and failure to do so leads to cell 
senescence and tissue dysfunction. The telomere is composed of both repetititive DNA and the 
shelterin complex of proteins which cap the telomeric DNA. Researchers characterized 
numerous phenotypes for mutants and knockdowns of shelterin and telomere-associated proteins 
like WRN which interact with the shelterin proteins. While rich and provocative, the cellular data 
cannot resolve the mechanisms underlying the phenotypes. Non-canonical, dynamic DNA 
structures like Holliday Junctions and G-quadruplexes further complicate the task of elucidating 
mechanisms in vitro. Single molecule methods such as AFM and spFRET provide an invaluable 
means to characterize the heterogeneous, dynamic DNA structures present at the telomere. We 
have characterized important mechanism of DNA structural modulation in both the “open” (i.e., 
undergoing replication, elongation or repair) telomere and also the closed (i.e., cells outside of S-
phase of non-dividing cells). 
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